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Sexually transmitted infections (STI) disproportionately affect adolescents, 
young adults, women and racial/ethnic minorities, leading to significant reproductive 
morbidities. Young minority women in the US are also at increased risk for unintended 
pregnancies, which coupled with STIs, can lead to serious complications in mothers and 
infants. Prevention of STIs in young minority women is greatly needed in order to 
improve reproductive and pregnancy health. However, interventions to reduce STIs in 
young minority women have had limited effectiveness. Furthermore, screening young 
women for chlamydia and gonorrhea is recommended but uptake is suboptimal. 
Syndemic theory hypothesizes that diseases co-occur and interact with other 
social afflictions to increase the risk of STIs. However, population-based studies on STI 
syndemics have not been conducted and statistical techniques are limited in determining 
how risk factors interact. In pregnant women, associations between STIs and perinatal 
outcomes are inconsistent but few studies have examined the effect of maternal factors 
such as age in adverse outcomes. This dissertation examined two statistical approaches 
to measure syndemics in a nationally representative sample of US young adults, and 
determined sex and race/ethnic specific profiles for STI risk. This dissertation also 
determined if perinatal outcomes following STIs are influenced by maternal age in 
minority women.  
The first study compared composite scoring and latent class analysis (LCA) to 




Examination Survey from 2011-2014. LCA identified different STI risk profiles that 
composite scoring alone could not.  Women with increased odds of STI (AOR: 2.19 CI 
95% 1.2-3.8) exhibited a syndemic of depression, substance use and sexual risk 
behaviors that composite scoring was unable to uncover. The second study, using the 
same dataset, applied LCA to determine race/ethnic specific STI risk profiles. 
Interestingly, Black females displayed more co-occurring risk factors (syndemic), 
despite lower sexual behavior risks compared to other women. The third study, 
examined a population of primarily minority pregnant women to determine if 
associations between Chlamydia trachomatis and perinatal outcomes are influenced by 
maternal age (a factor that influences screening). In young women (age <25), chlamydia 
was associated with medically indicated preterm birth (RRadj=2.25 95% CI 1.35-3.77). 
In older women (age > 25), no associations with preterm birth subtypes were found, but 
C. trachomatis was marginally associated with term preeclampsia (RRadj=1.49 CI 95% 
0.91-2.45). Further stratifications by race/ethnicity revealed an increased risk in 
chlamydia associated medically indicated preterm birth among white women, and 
preeclampsia among Black women. 
Modeling syndemics by sex and race identified risk profiles that can be utilized 
to develop culturally competent, targeted interventions to reduce STIs among minorities. 
Findings from the prenatal study suggest maternal age could influence outcomes 
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1. INTRODUCTION  
1.1. Sexually Transmitted Infections 
Sexually transmitted infections (STIs) are a significant public health concern, as 
they are increasingly prevalent in the United States and can lead to permanent 
reproductive damage and increased transmission of human immunodeficiency virus 
(HIV) 1. STIs include a myriad of bacterial and viral infections, such as Chlamydia 
trachomatis, Neisseria gonorrhoeae, syphilis, Trichomonas vaginalis, herpes simplex 
virus (HSV) and human papillomavirus (HPV), and are transmitted primarily through 
vaginal, anal and oral sex 1. In 2017 there were over two million cases of chlamydia, 
gonorrhea and syphilis reported to the Centers for Disease Control (CDC) 2. The 
prevalence of chlamydia was 528 per 100,000, gonorrhea was 171.9 per 100,000 and 
syphilis was 9.5 per 100,000 3. To put this in perspective, from 2013-2017 there was a 
67% increase in gonorrhea and 76% increase in syphilis. A total of 1.7 million cases of 
chlamydia were observed in the same year, making it the most reported disease to the 
CDC.  
Most concerning is that reportable STIs only represent a fraction of the true 
burden of disease 4. Although several STIs such as chlamydia, gonorrhea, syphilis and 
trichomoniasis can be cured through antibiotic treatment 5, an estimated 61-88% of 
chlamydia cases are asymptomatic 6. Similarly, 85% of trichomoniasis 7 8, 50% of 
gonorrhea 8, and an estimated 20-30% syphilis cases in the United States are 




significant reproductive complications 10 11.  Additionally, there is a significant concern 
over antibiotic resistant strains of gonorrhea 12 13.  
1.2. Age Specific Prevalence 
Adolescence and young adulthood (ages 15-24) are important periods for the 
development of intimate relationships 1, coping mechanisms such as alcohol and drug 
use 14, and STI risk behaviors 15.  This age group represents only 25% of the sexually 
active population, but accounts for half of all new reportable STIs in the United States 1. 
In an assessment of STI prevalence from a nationally representative sample of men and 
women from 1999-2008, chlamydia prevalence was estimated at 3.2% (CI 95% 2.26%-
4.52%) in women aged 15-24 and 1.66% (CI 95% 1.07%-2.55%) in men of the same age 
8. Gonorrhea prevalence was 0.62% (CI 95% 0.38%-1.03%) in women and 0.32% (CI 
95% 0.12%-0.84%) in men aged 15-24 8. Trichomoniasis prevalence was an estimated 
1.50% (CI 0.91%-2.44%) in women and the prevalence ratio was 1.64 (CI 95% 1.25-
2.15) among men age 15-24 8.  
Multiple factors may influence the higher prevalence of STIs among adolescents 
and young adults, including the introduction of mental health challenges 16, substance 
and alcohol use 17 18 and cultural or social factors 15 19. For example, in a cross sectional 
analysis of Project STYLE data collected between 2004-2007 from three site (Chicago, 
IL, Atlanta, GA, and Providence, RI) examining 840 adolescents evaluated for 
psychiatric disorders, the odds of risky sexual behaviors and STI positivity was higher 
among those with a diagnosed mental illness than individuals not meeting the criteria for 




community-wide longitudinal study in Pittsburgh, PA beginning in 2000, found that 
depression in 16 year old girls was predictive of any self-reported STI diagnosis (e.g., 
gonorrhea, chlamydia, herpes, HIV, genital warts) 20.  Sexual risk behavior was 
associated with self-reported STI in 17 year old girls, and greater alcohol use was 
predictive of self-reported STI in 18 year old girls, where frequency of alcohol use 
mediated the association in older girls 20.   
While most young people initiate healthy sexual relationships, others engage in 
health risk behaviors such as condomless sex and sex with multiple partners 15. For 
instance, while condoms remain the most popular form of contraception among 
adolescents, students from the Youth Risk Behavior Surveillance Survey reported 
roughly 57% used condoms at their last intercourse and 11% reported more than five 
sexual partners in their lifetime 14 21.  Further, in a longitudinal analysis of adolescents 
from Monitoring the Future from 1991-2015, 20% of 18 year old’s reported frequent 
binge drinking compared to less than 5% of 13-14 year old’s 22. And up to 60% of 
adolescents try or use illicit drugs by age 14 15. Alcohol and drug use impair judgment 
and may lead to risky sexual behaviors and increased risk of STIs 23.  
1.3. Disparities in Infection by Gender 
While young males and females are both at risk for STIs, young women are 
disproportionately affected by these pathogens 3. The prevalence of chlamydia in women 
(2.0, CI 95% 1.5-2.5) was higher than men (1.4, CI 95% 1.1-1.8) from a longitudinal 
analysis of nationally representative individuals age 14-39 11. It is estimated that one in 




may be at higher risk of contracting STIs due to cervical ectopy. This is where the 
columnar epithelium of the ectocervix extends to the proximal portion of the cervix 
leading to a thin vascular layer that is easily permeated by pathogens 24.  As a result, 
STIs are of particular concern for young women. For example, chlamydia and gonorrhea 
can lead to pelvic inflammatory disease and subsequent ectopic pregnancy, chronic 
pelvic pain or infertility 4 25. Untreated syphilis can cause neurological complications 
including altered behavior, paralysis, dementia, and even blindness 26 27.  
STIs are often asymptomatic for both men and women, but in young women (e.g. 
up to 80% of C. trachomatis cases are asymptomatic in women vs. 60% in males) may 
more frequently go untreated 6. In fact, due to their asymptomatic nature, screening for 
Chlamydia trachomatis and N. gonorrhoeae is recommended for women younger than 
25 years old to reduce reproductive complications in the population 5 28.  Unfortunately, 
screening uptake is poor 29.  Risk of STIs in this group is also influenced by women’s 
social and political standing in society, the availability of reproductive health services, 
violence perpetrated against women, and misinformation regarding contraception usage 
30 31. These are serious concerns as many STIs lead to more serious long-term 
consequence in women than men 32.  For example, C. trachomatis and N. gonorrhoeae 
can lead to pelvic inflammatory disease and subsequent long-term complications such as 
infertility 10 25, and HPV in women can lead to cervical cancer 33 34. Thus, further 
investigation into the particular STI prevention needs of women and girls should be a 





1.4. Racial/Ethnic Disparities  
Racial/ethnic disparities are immensely evident in STI and HIV rates. From 
2010-2014, Blacks accounted for just under half (45%) of all reported HIV infections in 
the United States 3 35. Black women (5.2, CI 95% 4.0-6.4) had five times the rate of 
chlamydia and Hispanic women (2.3, CI 95% 1.4-3.1) two times the rate as white 
women 11. Approximately 37% of all syphilis cases in 2016 were among Black 
individuals, with Black women having seven times the rate of white women 36.  Syphilis 
among pregnant women is also a particular concern due to the increasing rates (153% 
increase from 2013-2017) of congenital syphilis 3 37.  Black women accounted for 58.9 
per 100,000 of congenital syphilis cases in 2016 compared to 9.7 per 100,000 in white 
women 3 37. Disparities are similar among men, with Black men disproportionately 
affected by STIs when compared to white men 38-40.  A longitudinal study that included 
1,880 males aged 19-29 revealed that Black males had 4 times the odds of C. 
trachomatis compared to white males 40. 
 Black men and women are both consistently at increased odds of STIs when 
compared to their white counterparts, along with Hispanic men and women. Data from 
waves III and IV of National Longitudinal Study of Adolescent Health (Add Health) 
were examined to determine the population based estimates of STI risk in 11,045 young 
adults age 18-34 39.  Black (OR=2.5, CI 95% 1.9-3.0) and gay Black men (OR=5.4, CI 
95% 4.1-6.8) had significantly higher STIs compared to white men. Similarly, Black 
women (OR=1.3, CI 95% 0.9-1.7) and Black gay women (OR=11.6 CI 95% 3.0-20.1) 




white women 39.  Data from 27 US states between 2005-2008, shows that Hispanic men 
have 3 times the rate of primary and secondary syphilis compared to white men 41.  
Among 51,464 women diagnosed with chlamydia from 1992-2014 in King County, WA, 
the risk for Hispanic women was 32% 42.  Although racial/ethnic groups at high risk for 
STIs are well established, interventions that exclude social determinants of health and 
health equity and focus only on behavioral interventions to reduce STI rates have had 
limited effectiveness 43-45. Programs created without considering the contextual and 
socio-ecological influences on STI risk may not be sufficient to observe a widespread 
reduction of STI rates 46. 
1.5. Complications related to STIs during Pregnancy 
Prenatal acquisition of STIs are concerning if left untreated as infections may 
transmit from mother to infant during pregnancy, and result in significant pregnancy and 
delivery complications. For instance, the incidence of congenital syphilis has increased 
dramatically over the past five years from 8.4 to 11.6 cases per 100,000 4 37.  Similarly, 
Chlamydia has been associated with adverse birth outcomes including preterm birth, 
preterm premature rupture of membranes (PROM), and preeclampsia among others 10 47-
49.  Coinfection with any STI significantly increases the risk of HIV infection 4 50 51.  
Young women are at increased risk of unintended pregnancy and prenatal STIs 52 53, 
which are associated with adverse pregnancy outcomes 48 49. 
There are discrepancies in the association between chlamydia and specific 
adverse pregnancy outcomes, the reasons for which are not well understood. Preterm 




to chlamydia infection during pregnancy. Inconsistency in the findings from prenatal 
studies may be due to inconsistent definitions of the outcomes (e.g. preterm birth 
classifications), differences in the study designs, and lack of studies within large cohorts 
of high risk pregnant women. Furthermore, studies have not examined factors such as 
race and maternal age that may modify the risk of pregnancy outcomes following 
prenatal C. trachomatis 59. Providing support for specific adverse outcomes will be 
useful to determining effective screening recommendations for prenatal populations at 
high risk for infection. 
1.6. Assessing Multiple Risk Factors: A Syndemic Approach 
Traditional STI prevention programs focus on individual behaviors, but have not 
typically included sociological perspectives to health vulnerabilities and the needs of 
socially disadvantaged groups 43 46.  While sexual behaviors such as condomless anal and 
vaginal sex are well-known risk factors for STIs 60 61, reporting of those behaviors vary 
by gender and race/ethnicity among adolescents and young adults 62. Thus, aiming to 
modify certain sexual behaviors may not be effective for all groups 44.  For example, 
48.6% (95% CI 44.5%-52.7%) of males aged 14-19 reported two or more sex partners in 
the past year, compared to 39.4% (95% CI 35.5%-43.4%) of females aged 14-19 60.  In a 
longitudinal study of 13,998 adolescents from the Add Health, Black girls were least 
likely to report varied high-risk sexual behaviors, but are consistently more likely to test 
positive for STIs compared to non-Hispanic white girls 61. In another longitudinal study 
of 7015 adolescent girls from Add Health, Non-Hispanic white girls report engaging in 




compared to other race/ethnicities 62.  Hispanic girls reported low rates of condom use 
and fewer partners, but had partners at higher risk for STIs, while Black girls reported 
low rates of oral and anal sex with high rates of condom use, but had the most sexual 
partners with increased STI risk 62.  Risk behaviors may interact differently as a function 
of race/ethnicity and gender 46 61.  Therefore, it is recommended that future interventions 
focus on multiple behaviors, and psychosocial risks to effectively reduce STIs 19 63.  
 Syndemic theory may be applied to STI research to improve current prevention 
efforts 64. Syndemic theory suggests that diseases do not exist in isolation, but that 
multiple risk factors 64 or disease conditions 65 and the individuals social environment 
co-occur and interact to influence the course and outcome of disease 66.  The 
exacerbation of harmful social conditions can then compound health problems 67. 
Additionally, experiences of discrimination cluster health problems, intensifying how 
social systems such as racism and sexism reinforce specific challenges that perpetuate 
epidemics within certain populations 68 69.  Individuals at the intersection of syndemic 
factors seem to focus mainly on short term pleasure and have limited expectations of a 
future 70.  Social disparities in these contexts create an environment where high-risk 
behaviors may be more acceptable. Syndemic approaches encourage exploration of 
social institutions and environments that create risk and simultaneously produce 
disparities in disease outcomes in specific populations. Syndemics addresses the “failure 
to examine linked phenomena” while maintaining independence from simultaneously 




to advancing the development of culturally appropriate and targeted interventions to 
reduce disease among disparate populations 66 71 72.  
The syndemic framework was first used to understand the marginalized 
experiences of the HIV epidemic and how substance use, intimate partner and social 
violence were interrelated to increase HIV risk among men who have sex with men 
(MSM) 73-75.  A cross-sectional evaluation of 158 women living in a Connecticut 
community found that experiences with drug and alcohol use, depression, and post-
traumatic stress from previous intimate partner violence signified a syndemic that 
reduced the individuals capacity to negotiate condom use with partners 76.  Syndemics 
socially shape the distribution of disease and present a biologic synergism at the 
individual level 69.  Social impact factors such as violence indicators are associated with 
increased risk of STI, along with housing insecurity, childhood physical abuse, and 
depression 77.  Coulter et al. performed a cross-sectional evaluation of 467 sexual 
minority women ages 18-24 using a structural equations model and determined that 
syndemics were associated with discrimination related to sexual orientation 68.  In 
another cross-sectional evaluation of 151 adolescents and young adults ages 15-24 
recruited from the Transgender Young Project, results indicated that low self-esteem, 
polysubstance use, and intimate partner violence were indicators of a syndemic 
associated with increased risk of HIV 78.  These findings were further confirmed by 
Chakrapani and colleagues who evaluated 600 MSM and transgender women in India 




Syndemics for many marginalized populations included alcohol abuse, drug use, 
depressive symptoms, and risky sexual behaviors 73-75.  
Studies of syndemics in HIV are primarily amongst MSM 80-82 and sexual 
minorities 76 78. Furthermore, these studies focused on indicators of substance use and 
violence 83.  Examinations of syndemics among women in the context of HIV risk have 
also been conducted 75 84 85.  Women consistently have higher syndemic burdens 
compared to men in relation to HIV risk and subsequent infection due to societal 
disadvantage, particularly women of color 86.  Although syndemics are well examined in 
the HIV literature, other STIs and young adult populations have been relatively 
overlooked. One study of 199 Canadian adolescent women ages 13-17 determined that a 
syndemic of depression, substance use and sexual risk taking was associated with any 
STI risk 87.  Another longitudinal study of 125 young adult Mexican-American women 
determined that the prevalence of HSV-2 was 56.8%, and a syndemic  of co-occurring 
genital herpes, injection heroin use, Hepatitis C, previous sexual violence, incarceration, 
and mental illness was determined 88.  No other studies of this kind have been conducted 
in this population.  
Future examinations of syndemics in STIs should explore the extent to which 
risks interact to increase disease susceptibility or progression. Literature does not well 
document how multiple psychosocial problems contribute to the increased risk of STIs 
from syndemics 67 89 90.  Additionally, studies have overwhelmingly quantified 
syndemics through the use of composite scoring methods 91-93.  This approach assigns 




summarizes the number of problems reported by each participant. Higher scores from 
the count summaries are interpreted as a greater syndemic interaction 90.  Composite 
syndemic score methods were introduced to form baseline tests for interactions, not to 
determine the presence of syndemics, indicating that majority of syndemics literature are 
not using statistically comprehensive approaches to quantify the problem 70. Composite 
syndemic score methods may not produce estimates with clear implications for public 
health interventions or policies, test for interactions or identify synergies 90.  
1.7. Dissertation Aims 
This dissertation aims to improve scientific knowledge through identifying 
syndemic profiles for STI’s among young adults in the context of ecological perspectives 
and subsequently examining risk one prevalent STI and related outcomes in pregnancy. 
A prevalent STI, chlamydia, will be examined in a pregnancy cohort to determine 
associated pregnancy outcomes after infection.  This is important due to the high 
prevalence of chlamydia in the population and the long-term effects of asymptomatic 
and untreated chlamydia on women’s reproductive health. Next, a syndemic theoretical 
framework is proposed that includes social, behavioral, and mental health factors that 
may contribute to the increased risk of STIs among young adults. This goes beyond 
understanding the prevalence of STIs in this population to identifying specific risk 
factors that co-occur to increase risk. These studies are expected to result in gender and 
racial specific profiles of STI risk that may be further expanded to directly inform 
prevention activities. This innovative approach will include previously neglected gaps in 




1. To examine risk factors that may increase the odds of prenatal chlamydia and 
associated pregnancy outcomes among minority women. 
2. To compare multiple methods to quantify STI syndemics within a nationally 
representative sample of young adults.  
3. To determine if syndemics increase the odds for STIs in young adults by gender 
and race/ethnicity.  
The results obtained in these studies may be used to make informed recommendations 
for STI prevention programs targeting young adults, specifically by gender and 
race/ethnicity. Findings from these studies will improve the knowledge and 
understanding of specific pathways that influence racial and ethnic disparities for STIs in 





2. UNDERSTANDING FACTORS RELATED TO PRENATAL CHLAMYDIA 
TRACHOMATIS AND ASSOCIATED PERINATAL OUTCOMES 
2.1. Introduction 
According to Centers for Disease Control (CDC), in 2016 there were 1.59 
million cases of chlamydia in the U.S., a 4.7% increase since 2015 94.  Chlamydia 
trachomatis is a prevalent and predominantly asymptomatic bacterial sexually 
transmitted infection (STI) that increases the risk of pelvic inflammatory disease, 
causing infertility and ectopic pregnancy 95.   C. trachomatis  during pregnancy can lead 
to poor maternal and infant outcomes 96.  However, associations between C. trachomatis 
and specific adverse outcomes are largely conflicting 49 55 97.  Unfortunately, some 
minority populations remain underrepresented in studies of prenatal C. trachomatis and 
its effects on pregnancy outcomes. 
The reasons for the discrepant findings in studies of prenatal C. trachomatis and 
pregnancy outcomes are not clear. Preterm birth (delivery <37 weeks of gestation) has 
been extensively studied 56 98 99.  C. trachomatis was associated with preterm premature 
rupture of membranes (PROM) and preterm delivery in a population-based retrospective 
cohort study of infant birth certificates from 851 pregnant women in Washington state 49.   
In a retrospective cohort study of 357,217 women residing in Australia between 1999-
2008, C. trachomatis infection was marginally associated with stillbirth but not preterm 
birth 55.  A study of 194,045 pregnancies found reduced odds of preterm birth 98.  
Evidence suggests that C. trachomatis is also linked to preeclampsia; a maternal 




of cases 57.Others have found no associations between C. trachomatis and perinatal 
outcomes 99 100.     Inconsistent findings linking C. trachomatis to a specific adverse 
pregnancy outcome(s) may be due to different outcome definitions, inclusion of 
heterogeneous populations and differences in study design. Furthermore, adverse 
pregnancy outcomes such as preterm birth and preeclampsia have several subtypes with 
various etiologies that can impact the results of studies.  
The prevalence of chlamydia is much higher in young women than older women, 
which mimics the STI screening recommendations for pregnant women outlined by the 
US Preventative Services Task Force (USPSTF) and the CDC 5 101. The CDC 
recommends screening for all pregnant women, and the USPSTF suggest screening for 
pregnant women at high risk (e.g. history of STI, young age, history of sex work) for 
STIs. In 2015, the CDC changed prenatal C. trachomatis screening recommendations 
from all pregnant women to pregnant women less than 25 years old or women at 
increased risk of developing an STI 101.  Tao et al. suggest that differences in screening 
recommendations may be resulting in unreliable data that focuses on women in higher 
risk categories 59.  Chlamydia screening is based on the assumption that the probability 
of adverse outcomes is only dependent on population chlamydia prevalence 59.  
However, as Tao et al point out, if maternal age modifies the risk of adverse outcomes in 
chlamydia positive women, then the probability of those adverse outcomes will rely on 
both chlamydia prevalence and maternal age 59.  These findings supported increased 
testing among younger women as supported by the increased prevalence among this 




pregnancy outcomes was necessary. However, Tao et al., points out that it is unclear if 
factors such as race and maternal age modify the risk of pregnancy outcomes following 
prenatal C. trachomatis 59.  Young maternal age, race and  ethnicity are known risk 
factors for C. trachomatis infection during pregnancy 102, but both young and advanced 
maternal age are associated with adverse pregnancy outcomes.  Race and ethnicity are 
also well-known risk factor for several maternal and fetal complications 102.   
Furthermore, it is unknown if a woman with young maternal age have the same, lower, 
or higher risk of adverse pregnancy outcomes following infection compared to older 
women. Coupled with inconsistencies in identifying a specific adverse outcome related 
to prenatal chlamydia, further research in this area is needed.   
The objective of this study was to determine if prenatal C. trachomatis is 
associated with medically indicated preterm birth or spontaneous preterm birth in a large 
population of pregnant women. Additionally, since preeclampsia is a well-known 
indicator for preterm birth (~ 40% of medically indicated preterm births are due to 
preeclampsia) and has been linked to C. trachomatis infection 57, we examined 
associations between prenatal chlamydia and preeclampsia with and without a preterm 
delivery.  
2.2. Methods 
Data from the PeriBank repository was used in this retrospective cohort study 103.  
Briefly, women in PeriBank delivered at area hospitals in Houston, TX and were 
recruited by trained study personnel who approach eligible gravidae at the time of their 




variables of clinical information were directly extracted from electronic medical records 
and accompanying prenatal records. Charts were routinely audited by a board certified 
maternal-fetal medicine physician scientist to ensure quality of the data. PeriBank was 
approved by the Institutional Review Board at Texas Children’s Hospital and Baylor 
College of Medicine. The current study included participants with records cataloged in 
the PeriBank system from 2011-2017. Our analysis included 22,772 singleton 
pregnancies that had a confirmed prenatal C. trachomatis diagnostic test performed 
(100%). This study was approved by the Texas A&M University Institutional Review 
Board.  
2.2.1. Data Collection 
All laboratory information was abstracted from medical records. Provider 
collected vaginal swab and blood specimens were collected at first prenatal visit, 
processed and stored by clinical personnel trained in microbiology, pathology, and 
perinatal surgical expertise under uniformed protocol. Vaginal epithelial cell samples 
were collected and nucleic acid amplification tests (NAATs) and were performed as 
recommended by the American College of Obstetricians and Gynecologists (ACOG) and 
the Centers for Disease Control (CDC) to detect C. trachomatis and Neisseria 
gonorrhoeae 104 105.  Other genital infections included in the database were HIV, 
syphilis, bacterial vaginosis, hepatitis B, and genital herpes simplex virus (HSV)-2. 







Preterm birth was defined as delivery less than 37 weeks gestation determine by 
self-reported last menstrual period and confirmed with ultrasound. Ultrasound was used 
to mediate any discrepancies with last menstrual period. Subtypes of preterm birth were 
extracted from the patient medical record and classified as spontaneous or medically 
indicated. Spontaneous preterm births were defined as births from spontaneous labor or 
preterm premature rupture of membranes, while medically indicated preterm birth was 
classified as any maternal or fetal distress that resulted in medical intervention leading to 
delivery prior to 37 weeks. Due to the infrequency of preterm premature rupture of 
membranes (PROM) recorded in the medical records (0.10%), the variable was not 
included as an independent outcome.  
2.2.3. Maternal Characteristics 
Information was collected on maternal demographic characteristics, previous 
pregnancy complications, historical conditions, and fetal outcomes. Variables included 
maternal age, race, country of birth, marital status, education, income and insurance 
type. Smoking, drug and alcohol use were asked at the time of triage for the past year 
and included in the model. Previous pregnancy information of interest were gravida and 
parity, comorbidities (i.e. congenital heart defects, hypothyroidism, diabetes, 
preeclampsia, hypertension, or seizure disorders), and previous pregnancy or birth 
complications. Biometric measures of body mass index (BMI), blood pressure, height 
and weight were also collected. Current pregnancy information included gestational age 




birth, the infant sex, chorioamnionitis, preeclampsia or normal blood pressure 
(normotensive).   
2.2.4. Statistical Analysis  
Modified Poisson regression 106 with robust error measurements was used to 
estimate relative risk (RR) and 95% confidence intervals (CI) for all analyses. It is well 
known that odds ratios are often used to approximate relative risk (RR) or prevalence 
ratios (PR) but often lead to overestimations for non-rare events 106.  There are several 
methods well described in the epidemiologic literature to directly calculate RR or PR 
rather than relying on OR to estimate risk. Two common methods are log-binomial 
logistic regression and modified Poisson regression with robust (generalized estimating 
equations (GEE) or “sandwich”) variance estimates (used for binary data) 107.  Log-
binomial regression was initially used however, this method is less numerically stable 
and there were issues with convergence. A limitation of Poisson are conservative 
confidence limits and overestimates of binomial errors.  However, the sandwich variance 
estimate (i.e. the modified version) avoids the conservative confidence intervals and 
produces similar estimates to other approaches.  This approach has been validated in 
SAS using the GENMOD procedure with the REPEATED ESTIMATES statement and 
is an accepted and appropriate method for this data 108.  
Univariate analysis examined associations between demographic and clinical 
variables and C. trachomatis infection. PR and 95% confidence intervals (CI) are 
reported. Known risk factors for chlamydia were included in the models to control for 




previous preterm birth) may not need to be adjusted for in perinatal studies estimating 
the effect of an exposure on an outcome 109. Specifically, the effect of a previous preterm 
birth on a subsequent preterm birth is heavily influence by the gestational age of that 
previous birth 54, which was not available in this study. Therefore, previous preterm birth 
was not adjusted for in this analysis. Multivariable analyses were used to examine 
associations between C. trachomatis and adverse birth outcomes. Model 1 included no 
adjustments for covariates and examined the crude association between C. trachomatis 
and preterm birth subtypes.  Model 2 included adjustments for maternal age, 
race/ethnicity and foreign born status (where necessary), marital status, education, 
insurance type, alcohol use, and gestational age at first prenatal visit.  Model 3 included 
adjustments in model 2 in addition to a composite STI variable (HIV, Neisseria 
gonorrhoeae, bacterial vaginosis, group B streptococcus and syphilis) to consider 
confounding related to co-infections, and any reported maternal comorbidities as 
indicated in the patient medical record. The variable HSV-2 was not included in the 
model 3 adjustments due to the high number of missing, although significantly 
associated with chlamydia positivity. Lower urinary tract infection was also excluded in 
model 3 due to its low prevalence in the sample.  Further analysis was conducted 
stratified by age less than 25 and greater than or equal to 25 and by race/ethnicity. All 
analysis were conducted in SAS V9.4 (Cary, NC).  
2.3. Results 
2.3.1. Descriptive results 




CI 0.70-0.71), Hispanic (62.5%, 95% CI 0.62-0.63), foreign-born (61.6%, 95% CI 0.61-
0.62), married (64.0%, 95%CI 0.64-0.65), and were Medicaid or CHIP recipients 
(67.1%, 95% CI 0.67-0.68). Prevalence of C. trachomatis was 4.3% and was the most 
frequently diagnosed STI. Trends for chlamydia increased from 2011-2015 then 
decreased over the remaining years with younger women having a higher prevalence. 
Prenatal C. trachomatis was significantly associated with younger age (PR=3.5, 95% CI 
3.1-4.0), black race (PR=4.3, 95% CI 3.2-5.8), Hispanic ethnicity (PR=2.1, 95% CI 1.4-
3.2) being unmarried (PR=3.05 95% CI 3.1-4.0), being less educated (High school 
graduate PR=5.0, 95% CI 3.2-8.0) and having no insurance (PR=5.4, CI 95% 3.7-7.7) 
(Table 2.1). Cesarean deliveries were lower among women with C. trachomatis 
(PR=0.81, 95% CI 0.70-0.93). Women who had their first prenatal visit in the third 
trimester were more likely to have C. trachomatis infection (PR=1.77, 95% CI 1.3-2.4) 
than women who received prenatal care in the first trimester, however most women 
engaged in prenatal care in their first trimester (n=11040, 56%).  
The overall prevalence of preterm birth was 9.4%. Spontaneous preterm birth 
(3.6%, 95%CI 0.03-0.04) was the most commonly reported subtype, followed by 
medically indicated (3.4%, 95% CI 0.03-0.04). Preeclampsia prevalence was 7% 
(n=1467) in the population.  Of those preeclampsia cases, half were preterm 






Table 2.1. Maternal characteristics and prevalence rates by C. trachomatis status N=22,772. 
Variable Chlamydia 
negative n (%) 
Chlamydia 
positive n (%) 
PR 95% CI 
Demographics 
Maternal age 
35> (ref) 4627 (213%) 73 (7.5%) -- -- 
25-34 12040 (55.3%) 378 (38.7%) 1.96 1.53-2.51 
<25 5094 (23.4%) 525 (53.8%) 3.84 2.34-6.31 
Race 
NH White (ref) 3914 (18.0 %) 45 (4.6%) -- -- 
NH Black 2770 (12.7%) 201 (20.6%) 4.29 3.18-5.79 
Hispanic 13520 (62.1%) 693 (70.9%) 2.07 1.35-3.17 
Other* 1566 (7.2%) 38 (3.9%) -- -- 
Country of birth 
US-born (ref) 7795 (38.2%) 390 (42.2%) -- -- 
Foreign born 12585 (61.7%) 533 (57.7%) 0.85 0.75-0.97 
Marital status 
Married (ref) 13849 (65.3%) 344 (35.8%) -- -- 
Unmarried  7369 (34.7%) 617 (64.2%) 3.05 3.09-3.96 
Education 
College (ref) 5543 (29.7%) 56 (6.6%) -- -- 
Some College 1999 (10.7%) 118 (13.9%) 0.91 0.74-1.13 
High School  4076 (21.8%) 265 (31.2%) 5.01 3.24-8.00 
Less than High School 7041 (37.8%) 409 (48.3%) 28.4 13.4-60.0 
Insurance type 
Private (ref) 5435 (25.6%) 47 (4.9%) -- -- 
Medicaid/CHIP 14104 (66.3%) 792 (83.3%) 0.87 0.71-1.05 
None/other  1718 (8.1%) 112 (11.8%) 5.39 3.75-7.74 
Behavioral risk factors 
Alcohol 
No (ref) 16500 (75.7%) 845 (86.6%) -- -- 
Yes 5285 (24.3%) 131 (13.4%) 0.50 0.41-0.60 
Smoking 
No (ref) 19812 (90.9%) 886 (90.8%) -- -- 
Yes 1976 (9.1%) 90 (9.2%) 1.02 0.82-1.26 
Previous pregnancy information 
Number of previous pregnancies 
1 5628 (25.8%) 322 (33.0%) -- -- 
2 or more 16167 (74.2%) 655 (67.0%) 0.72 0.63-0.82 
Previous Preterm births 
No (ref) 19668 (90.2%) 899 (92.0%) -- -- 
Yes 2127 (9.8%) 78 (7.9%) 0.81 0.64-1.02 
Previous abortion 
No (ref) 15366 (70.5%) 730 (74.7%) -- -- 
Yes 6429 (29.5%) 247 (25.3%) 0.82 0.71-0.94 
Infections 
Lower Urinary tract infection 
Negative (ref) 20830 (95.6%) 895 (91.6%) -- -- 






Table 2.1. Maternal characteristics and prevalence rates by C. trachomatis status N=22,772, 
Continued 
Variable Chlamydia 
negative n (%) 
Chlamydia 
positive n (%) 
PR 95% CI 
Negative (ref) 21327 (97.8%) 915 (93.7%) -- -- 
Positive 468 (2.2%) 62 (6.3%) 2.84 2.23-3.62 
Herpes Simplex Virus-2 
Negative (ref) 961 (62.1%) 586 (51.6%) -- -- 
Positive 49 (37.9%) 46 (48.4%) 1.50 1.02-2.22 
Hepatitis B 
Negative (ref) 21333 (99.3%) 953 (99.4%) -- -- 
Positive 153 (0.7%) 6 (0.6%) 0.88 0.40-1.94 
Neisseria gonorrhoeae 
Negative (ref) 21417 (99.7%) 873 (91.7%) -- -- 
Positive 56 (0.3%) 79 (8.3%) 14.9 12.8-17.5 
Group B Streptococcus 
Negative (ref) 15165 (76.7%) 673 (76.5%) -- -- 
Positive 4596 (23.3%) 207 (23.5%) 1.01 0.87-1.18 
Syphilis 
Negative (ref) 21423 (99.4%) 953 99.2%) -- -- 
Positive 139 (0.6%) 8 (0.8%) 1.28 0.65-2.51 
HIV 
Negative (ref) 17798 (99.2%) 790 (98.0%) -- -- 
Positive 140 (0.8%) 16 (2.0%) 2.41 1.51-3.86 
Current pregnancy 
Gestational age at first prenatal visit 
1-12 weeks (ref) 10700 (56.3%) 340 (39.7%) -- -- 
13-27 weeks 6863 (36.1%) 422 (49.2%) 0.94 0.76-1.17 
28-41 weeks 1448 (7.6%) 95 (11.1%) 1.77 1.33-2.36 
Delivery outcome 
Live Birth (ref) 217490 (99.8%) 973 (99.6%) -- -- 
Still birth 49 (0.2%) 4 (0.4%) 1.76 0.69-4.53 
Intrauterine Growth Restriction 
No (ref) 21613 (99.2%) 970 (99.3%) -- -- 
Yes 182 (0.8%) 7 (0.7%) 0.86 0.42-1.79 
Delivery route 
Vaginal (ref) 15562 (71.5%) 740 (75.7%) -- -- 
Cesarean 6209 (28.5%) 237 (24.3%) 0.81 0.70-0.93 
Infant sex 
Female (ref) 10595 (48.7%) 465 (47.6%) -- -- 
Male 11158 (51.3%) 511 (52.4%) 1.04 0.92-1.18 
Modified Poisson regression with robust error measurements were used to calculate 





Table 2.2 displays associations between C. trachomatis and preterm birth 
subtypes. C. trachomatis was not significantly associated with overall preterm birth 
(model 3: RR=1.09 CI 95% 0.86-1.39) after full adjustments. However, there was a 
statistically significant association between C. trachomatis and medically indicated PTB 
after adjustments (model 3: RR=1.58 95% CI 1.09-2.28). Associations with C. 
trachomatis and term preeclampsia were also found in the fully adjusted model (model 3: 
RR=1.46 CI 95% 1.06-2.01). No other associations were found within the overall 




Table 2.2. Association between Chlamydia trachomatis and pregnancy outcomes among singleton 
pregnancies N=22,772, 2011-2017.   





Model 1¥ Model 2 β Model 3± 
   RR (CI 95%) RR (CI 95%) RR (CI 95%) 
 GA at delivery 






-- -- -- 






1.13 (0.93-1.36) 1.10 (0.87-1.40) 1.09 (0.86-1.39) 
Indicated 
PTB 
683 (3.3%) 46 (4.1%) 1.60 (1.11-2.30) 1.53 (1.13-2.07) 1.58 (1.09-2.28) 
Spontaneous 
PTB 
730 (3.6%) 33 (3.6%) 1.02 (0.73-1.44) 0.88 (0.56-1.36) 0.86 (0.55-1.34) 







-- -- -- 
Overall PE 1389 (7.0%) 78 (8.8%) 1.26 (1.02-1.57) 1.24 (0.97-1.59) 1.19 (0.93-1.52) 
Term PE  676 (3.4%) 50 (5.8%) 1.66 (1.25-2.19) 1.50 (1.09-2.05) 1.46 (1.06-2.01) 
Preterm PE 713 (3.5%) 28 (3.4%) 0.90 (0.62-1.31) 0.97 (0.64-1.48) 0.90 (0.59-1.38) 
 Chorioamnionitis 




-- -- -- 
Yes 1196 (5.5%) 72 (7.5%) 1.34 (1.07-1.69) 1.05 (0.83-1.33) 0.95 (0.72-1.25) 
Modified Poisson regression with robust error measurements were used to calculate unadjusted 
relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for maternal age, race, foreign born status, marital status, education, 
insurance type, alcohol and gestational age at first prenatal visit 





We did not have timing of infection available for analysis. However, most 
women are tested for C. trachomatis at the first prenatal visit. Accounting for gestational 
age at first prenatal visit did not alter the results. No significant associations were 
observed between C. trachomatis and preterm birth subtypes among women who 
initiated care in the first trimester. There was, however, an association with term 




2.51).  Among women with second trimester initiation of care, C. trachomatis was 
associated with medically indicated preterm birth after full adjustments (model 2: 
RR=1.74 95% CI 1.03-2.95). No other associations were found in this group.  Among 
women who initiate care in the third trimester, no significant associations were observed 
for any outcomes before or after adjustments [overall preterm birth (model 3: RR= 1.53 
95% 0.68-3.44)].  
As a secondary analysis, we explored associations between other genital 
infections and preterm birth subtypes. Bacterial vaginosis (2.33% 95% CI 0.214-0.253), 
HIV (0.83%, 95% CI 0.007-0.010), syphilis (0.65%, 95% CI 0.006-0.008), Neisseria 
gonorrhoeae (0.60% 95% CI 0.005-0.007), and hepatitis B (0.71% 95% CI 0.006-0.008) 
were of interest for this analysis. HIV was significantly associated with medically 
indicated preterm birth (model 3: RR=2.32 95% CI 1.31-4.11), spontaneous preterm 
birth (model 3: RR=2.36 95% CI 1.33-4.19), and preeclampsia with a term delivery 
(model 3: 1.98 95% CI 1.13-3.48).  Syphilis was marginally associated with 
preeclampsia with a term delivery (model 3: RR=1.81 CI 95% 1.0-3.43). There were no 
associations found with Neisseria gonorrhoeae in any model. 
2.3.2. Preterm birth subtypes by Race, Ethnicity and Foreign -born status 
 Chlamydia associated outcomes were examined by race, ethnicity, and foreign-
born status. Among white women (n=3,959), a chlamydia associated medically indicated 
preterm was found all models (model 3: RR=2.30 CI 95% 1.06-5.01). No other 
associations were found among preterm birth subtypes. The sample of women with 




calculated.  Among Black women (n=2,971) there were no associations found with 
preterm birth or subtypes in any of the adjusted models. However, the risk of 
preeclampsia (model 3: RR=1.76 CI 95% 1.12-2.75) and term preeclampsia (model 3: 
RR=2.46 CI 95% 1.21-4.98) was significantly increased. Hispanic women (n=14,213) 
had no chlamydia associated pregnancy outcomes in fully adjusted models, but did have 
a marginally significant relationship with chlamydia and term preeclampsia (model 3: 
1.39 CI 95% 0.97-2.00). Among foreign-born women (n=13,118), no fully adjusted 
models were significant with any outcome. 
2.3.3. Age adjusted analysis 
We determined if there were differences in the association between C. 
trachomatis and preterm birth subtypes by maternal age.  In women < 25 years 
(n=5,654) (Table 2.3), C. trachomatis infection was significantly associated with 
medically indicated preterm birth after full adjustments (model 3: RR=2.25 95% CI 
1.35-3.77) and with chorioamnionitis (model 3: RR=1.45 CI 95% 107-1.96). No other 
significant associations were found. Among women >25 years (n=17,118) shown in 
Table 2.4, C. trachomatis was significantly associated with term preeclampsia in the 
unadjusted (model 1: RR=1.64 CI 95% 1.07-2.52) but not the adjusted models (model 2: 






Table 2.3. Association between Chlamydia trachomatis and pregnancy outcomes in singleton pregnancies for women < 25 years 
N=5619, 2011-2017.   
Variable CT negative n (%) CT positive n (%) Model 1¥ Model 2 β Model 3± 
   RR (CI 95%) RR (CI 95%) RR (CI 95%) 
GA at delivery 
Term > 37 weeks (ref) 4677 (91.2%) 470 (89.3%) -- -- -- 
Preterm < 37 weeks 451 (8.8%) 56 (10.6%) 1.21 (0.93-1.57) 1.29 (0.94-1.77) 1.31 (0.96-1.80) 
Indicated PTB 124 (2.6%) 26 (5.2%) 2.04 (1.35-3.08) 2.24 (1.34-3.72) 2.25 (1.35-3.77) 
Spontaneous PTB 179 (3.7%) 21 (4.3%) 1.16 (0.75-1.81) 1.18 (0.70-2.00) 1.19 (0.70-2.03) 
Preeclampsia (PE) 
Normotensive (ref) 4323 (92.2%) 421 (90.1%) -- -- -- 
Overall PE 368 (7.8%) 46 (9.8%) 1.26 (0.94-1.68) 1.36 (0.99-1.87) 1.32 (0.96-1.82) 
Term PE  215 (4.7%) 29 (6.4%) 1.36 (0.93-1.98) 1.49 (0.99-2.24) 1.46 (0.96-2.21) 
Preterm PE 153 (3.4%) 17 (3.9%) 1.14 (0.69-1.86) 1.23 (0.71-2.12) 1.18 (0.68-2.04) 
Chorioamnionitis 
No (ref) 4645 (91.6%) 465 (89.4%) -- -- -- 
Yes 427 (8.4%) 55 (10.6%) 1.26 (0.96-1.64) 1.45 (1.07-1.94) 1.45 (1.07-1.96) 
Modified Poisson regression with robust error measurements were used to calculate unadjusted relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for race, foreign born status, marital status, education, insurance type, alcohol and gestational age at first 
prenatal visit 










Table 2.4. Association between Chlamydia trachomatis and pregnancy outcomes among singleton pregnancies among women 
> 25 years N=17,118, 2011-2017.  
Variable CT negative n (%) CT positive n (%) Model 1¥ Model 2 β Model 3± 
   RR (CI 95%) RR (CI 95%) RR (CI 95%) 
GA at delivery 
Term > 37 weeks (ref) 15078 (90.5%) 404 (89.6%) -- -- -- 
Preterm < 37 weeks 1589 (9.5%) 47 (10.4%) 1.09 (0.83-1.44) 0.77 (0.53-1.13) 0.78 (0.53-1.14) 
Indicated PTB 559 (3.6%) 20 (4.7%) 1.32 (0.86-2.04) 1.01 (0.57-1.76) 1.01 (0.57-1.78) 
Spontaneous PTB 551 (3.5%) 12 (2.9%) 0.82 (0.47-1.44) 0.44 (0.18-1.05) 0.43 (0.18-1.04) 
Preeclampsia (PE) 
Normotensive (ref) 14195 (93.3%) 385 (92.3%) -- -- -- 
Overall PE 1021 (6.7%) 32 (7.7%) 1.14 (0.82-1.60) 1.03 (0.70-1.53) 1.01 (0.68-1.50) 
Term PE  461 (3.1%) 21 (5.2%) 1.64 (1.07-2.52) 1.50 (0.92-2.47) 1.49 (0.91-2.45) 
Preterm PE 560 (3.8%) 11 (2.8%) 0.73 (0.41-1.32) 0.63 (0.32-1.26) 0.61 (0.31-1.22) 
Chorioamnionitis 
No (ref) 15762 (95.4%) 430 (96.2%) -- -- -- 
Yes 769 (4.6%) 17 (3.8%) 0.82 (0.51-1.31) 0.90 (0.52-1.54) 0.88 (0.50-1.54) 
Modified Poisson regression with robust error measurements were used to calculate unadjusted relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for race, foreign born status, marital status, education, insurance type, alcohol and gestational age at 
first prenatal visit 







Screening for C. trachomatis during pregnancy is significant since approximately 
80% of infections are asymptomatic and may go undetected 110.  However, screening 
uptake is suboptimal in the population. A study of over 1 million pregnant women found 
that screening rates vary from 72% in young women (<25 years of age) to only 59% in 
older women, which is reflective of most screening recommendations 110.  Currently, 
CDC and the U.S. Preventive Service Task Force (USPSTF) have somewhat conflicting 
screening recommendations for pregnant women 101 111.  CDC recommends that all 
pregnant women under the age of 25 and older pregnant women at increased risk for an 
STI are screened at their first prenatal visit. Recommendations extend to the third 
trimester only if the women are under 25 or at continued high risk. USPSTF suggest 
pregnant women at increased risk of developing an STI are screened, but routine 
screening of women not at increased risk is not recommended 101.  Increased risk 
includes women with a previous STI diagnosis, multiple sexual partners, or have a 
history as a sex worker 101.  
Among the entire cohort, there was a significant increase in the risk of medically 
indicated preterm birth, particularly earlier onset (<35 weeks), following prenatal 
chlamydia. After stratifying by race and ethnicity, the results showed that Black women 
were at increased risk of preeclampsia following prenatal chlamydia, while white 
women had increased risk of indicated preterm birth, while Hispanic women had 
marginal associations with term preeclampsia. Foreign born had no association with any 




categories (<25) and white were at significant risk of C. trachomatis infection and 
subsequent medically indicated preterm birth, while Black women were at significant 
risk of infection and preeclampsia. However, those in the higher age category (>25) 
seemed to trend towards an increased risk for term preeclampsia. Thus, our data found 
age-specific and race/ethnicity specific differences in the risk of adverse pregnancy 
outcomes following prenatal chlamydia as requested by Tao et al 59.   
Medical indication for a preterm birth may include preeclampsia, small for 
gestational age, intrauterine growth restriction, unexpected bleeding, placental abruption, 
maternal chronic conditions and fetal distress 54 112.  Genital tract infections may cause 
systemic and local inflammation of the maternal/fetal membranes 54.  Inflammation is 
associated with several adverse pregnancy outcomes related to medically indicated 
preterm birth, including preeclampsia and growth restriction 113.  To the author’s 
knowledge, no other study has found an association between C. trachomatis and 
medically indicated preterm birth. Furthermore, studies on maternal age and indication 
of preterm delivery are rare.  
We found a marginal association between prenatal C. trachomatis and term 
preeclampsia, among Black women and older women. Although not statistically 
significant in the fully adjusted model, the effect size remained similar. Preeclampsia is a 
systemic maternal syndrome affecting 3-8% of pregnancies and is a leading cause of 
maternal mortality 114.  Furthermore, Black women are disproportionately affected by 
preeclampsia and related mortality in the United States 115. Preeclampsia is clinically 




organ dysfunction 114.  Preeclampsia is considered a heterogeneous syndrome consisting 
of subtypes (e.g. early vs. late onset) with different underlying pathologies 116.  Prenatal 
C. trachomatis, infection may trigger an inflammatory response, which perhaps in older 
women increases the risk of preeclampsia later in gestation. Two studies have found 
associations between C. trachomatis and preeclampsia 57 58.  These studies suggested 
increases in trophoblast dysfunction after changes in uterine vascularization following C. 
trachomatis my lead to the maternal syndrome.  
This study has several strengths. We utilized a robust dataset from a data 
repository that allowed differentiation of preterm birth subtypes 103.  Although 
misclassification of some variables with medical record data is possible, PeriBank cross 
checks medical records and data is imputed to limit this possibility. A few limitations 
persist, including generalizability due to the population being primarily Hispanic. 
However, Hispanics have a higher prevalence of chlamydia than whites and fewer 
prenatal chlamydia studies have focused on this group. Thus, our study adds to the 
current literature on prenatal chlamydia in Hispanic populations. Although adjustments 
were made for known confounders, there is still potential for residual confounding. 
Future analysis on complete data with previous pregnancy history and outcomes may 
allow for proper adjustments in the model. Treatment failure, re-infection and test of 
cure data was unavailable. Although, standard treatment for C. trachomatis has an 
efficacy of 97% 117.  We also did not have data on timing of infection, but used the 
gestational age of prenatal care initiation as an indicator of timing. Generally, chlamydia 




likely to have a late first prenatal visit. 
2.5. Conclusion 
The objective of this study was to determine perinatal outcomes associated with 
prenatal C. trachomatis. This study suggested an association between C. trachomatis and 
medically indicated preterm birth among young white women, but not other preterm 
birth subtypes. We also found a significant relationship between C. trachomatis and term 
preeclampsia among Black and older women. It is possible that chlamydia triggers 
preeclampsia, and therefore early screening and treatment may reduce the likelihood of 
the onset of preeclampsia. Prospective evaluations are needed to better understand if 
maternal age modifies adverse outcomes following prenatal C. trachomatis and a larger 





3. EXAMINING STATISTICAL METHODS TO EVALUATE SYNDEMICS 
3.1. Introduction 
Syndemics theory proposes that disease risk and progression are influenced by 
multiple co-occurring or interacting factors. For example, multiple diseases, social 
conditions, and environment intermingle to modify the susceptibility and progression of 
a disease in an individual 64 70.  For infectious diseases, syndemics can intensify 
pathogenic contagiousness, accelerate virulence, and exaggerate symptoms 69. 
Syndemics may work through alteration of immunological and biochemical processes 
such as stress induced immune degradation 64, and create changes in mental health and 
coping strategies 69.  Experiences of discrimination may further cause diseases to cluster, 
intensifying how social systems such as racism and sexism reinforce specific challenges 
that perpetuate epidemics within certain populations 68 118.  
Applying a syndemic framework to sexual health and STI prevention is vital to 
advancing the development of culturally appropriate and targeted interventions to reduce 
disease among disparate populations 72.  For example, in a cross-sectional study of 564 
HIV positive women of color, women who exhibited syndemics were less likely to 
virally suppressed, an indicator of treatment adherence in HIV positive individuals 71.  In 
another cross-sectional analysis of 467 sexual-minority women age 18-24, a syndemic 
defined as a combination of heavy alcohol consumption, polysubstance use, depressive 
symptoms, sexual behavioral risk factors and history of sexually transmitted infections 




have examined syndemics in relations to STIs and methods to define a syndemic are not 
standardized.  
Traditional approaches to evaluating syndemics in STIs and HIV have applied 
syndemic scoring statistical methodologies to quantifying co-occurring social and 
behavioral conditions 67 89 90.  Studies assign a score to social conditions and summarize 
those scores to indicate the presence of a syndemic, and the scale of the syndemic is 
dependent on the number of psychosocial indicators evaluated in the study. Higher 
values given to a syndemic through the generated score typically elucidates a dose-
response effect. These syndemic scores are then incorporated into a logistic regression 
model to calculate the odds of disease. For instance, a cross-sectional evaluation of 300 
male sex workers found that a syndemic score of four or more psychosocial health 
problems was associated with sexual risk behaviors 119.  A cross-sectional study of 
82,812 adolescents in grade 7-12 found as the syndemic score (five or more indicators 
OR= 9.45 CI 95% 7.6-11.8) increased so did the risk of adolescent substance use, a 
factor that is related to STI risk 120.  In both studies, as the syndemic score increased risk 
was higher. In a longitudinal analysis of 799 HIV-uninfected women, a syndemic of low 
education, low income, unemployment, publicly funded health insurance, housing 
instability, substance and alcohol use, intimate partner violence, and previous 
incarceration was associated with increased risk of HIV 121.   
Although syndemic scoring methods may provide some understanding of the 
intensity of a syndemic in a particular population, it may not allow for results that may 




to select variables for subsequent interaction tests 70 90.  However, most studies only 
examine the syndemic score, which does not determine the interacting effects of co-
occurring risks or conditions 90.  Indeed, Tsai and others 122-124 have extensively 
published on the limitations of syndemic scores indicating that the landmark syndemics 
study by Singer and Clair 70 explicitly states that summary methods are not adequate to 
detect interactions 90.  Thus, other methods to test for co-occurrence of factors leading to 
a syndemic need to be utilized 90; such as latent class analysis 83 125 126.  
Latent class analysis (LCA) is a finite mixture latent modeling approach that 
assists in identifying subgroups based on observed qualities or characteristics 127-129.  
This approach assumes that a population contains latent subgroups that can be comprised 
of intersecting characteristics and is useful in identifying these subgroups using a 
multitude of observed characteristics across dimensions 130 131.  Social and behavioral 
health researchers have long used LCA as a tool to demonstrate unobserved categories 
that may explain observed outcomes such as HIV 83 125 126 and substance abuse 132-134. 
Latent class can be applied to increase the understanding of the specific needs of a 
population. For example, a latent class analysis of 4,158 individuals from a longitudinal 
study revealed five classes of adolescent sexual behavior, of which, high risk classes 
were  related to young adult STI rates 135.  Cleland and colleagues in a cross-sectional 
analysis of 2,853 Black and Hispanic adults, found that health literacy and emotional 
support were associated with substance use 133. LCA is an emerging method to 
understand how syndemic factors affect individuals in a heterogeneous group. The 




for STI prevention and allow for the development of targeted prevention strategies for 
effective programs. 
 Robust statistical approaches to evaluate syndemics may allow for better 
interpretability of results and translation to prevention. Therefore, the purpose of this 
study is to conduct a syndemic score and latent class analysis to examine the syndemics 
of STI risk among a representative sample of young adults age 18-25 in the United 
States.  
3.2. Methods 
3.2.1. Study population 
This was a cross-sectional analysis of individuals aged 18-25 interviewed for the 
National Health and Nutrition Examination Survey (NHANES) from two waves, 2011-
2012 and 2013-2014. The NHANES is a multistage probability survey that incorporates 
sample weights for oversampling minority groups, clustering and stratum to be 
representative of the general United States population 136. Data were collected through 
collaborations with the Centers for Disease Control and Prevention (CDC) and the 
National Center for Health Statistics (NCHS) through physical exams and household and 
individual interviews 136.  Physical examinations were completed at a designated medical 
examination center (MEC), where anthropometric measures and biological samples were 
collected. A total of 15,869 adults aged 18 and older were interviewed between 2011-
2014, and of those, 1,900 were aged 18-25. Individuals over the age of 25 (n=13,969) 
were excluded, and subjects were further excluded if they did not have a determinant test 




Immunodeficiency Virus (HIV) (n=97). The remaining 1,803 subjects were included for 
analysis.  
3.2.2. Demographics 
The NHANES provides a representative sampling of gender, age, and race for 
analytic purposes. Ages 18-25 were included for this analysis to observe adolescent and 
young adult syndemic characteristics, along with gender and race of the individual. Race 
was collected for non-Hispanic White, Non-Hispanic Black, Mexican American and 
Hispanic, Asian, mixed race and individuals that selected other race. As the sample of 
Asian, mixed and other race individuals was low, other, mixed race and Asians were 
combined to create a combined “other” category. Additional demographics of interested 
were head of household and household information such as number of people living in 
the household (1-4 or 5+), the country of birth (US or other) for the head of household, 
poverty index ratio (< 1.3), head of household education (high school graduate or less) 
and marital status (unmarried). 
3.2.3. Sexual Transmitted Infections  
Urinary and serum samples were used for laboratory analysis and confirmatory 
testing for STIs. Chlamydia trachomatis (CT) and Herpes Simplex Virus-2 (HSV-2) 
were diagnosed by nucleic acid amplification test (NAAT) 137 and HIV was diagnosed 
through synthetic peptide enzyme immunoassay (EIA) 101.  A composite variable for STI 
was created if subjects were positive for any of the STIs (Chlamydia trachomatis, 
Herpes Simplex Virus II, or HIV). These variables were included due to their 




3.2.4. Mental health 
Mental health was assessed using the 9-item Patient Health Questionnaire (PHQ-
9). The PHQ-9 is a widely used and well-validated screener of depression severity and 
symptoms in youth 138.  There were 9 questions assessing depressive symptoms in the 
two weeks before the survey with four response categories (0-3) denoting the occurrence 
and frequency of depressive symptoms. These were summed for an overall score ranging 
from 0 to 27 139.  A score of 10 or greater is considered the threshold for depression, and 
was used as the cut point in this study 139.  
3.2.5. Illicit drug use 
The drug use questionnaire (DUQ) administered through the NHANES was used 
to assess past year use of marijuana or hashish, cocaine, heroin, and methamphetamine. 
Questionnaires are self-administered using the audio computer-assisted self-interview 
(ACASI) system and were conducted in the MEC. Questions asked, “Have you ever, 
even once, used marijuana or hashish?” and “Have you ever used cocaine, crack cocaine, 
heroin, or methamphetamine?” to establish baseline use of illicit drugs. Due to non-
response and missingness in the more detailed questions, the ever use questions were the 
only included for this analysis.  
3.2.6. Alcohol use 
The alcohol use questionnaire assessed frequency of alcohol consumption in the 
past year. Participants were classified as regular alcohol users if they were men who 





3.2.7. Smoking status 
To accurately assess nicotine levels from tobacco smoking serum cotinine levels 
were assessed. The NHANES chooses to collected serum measures of cotinine for 
quantitative assessment of exposure. Cotinine is the primary metabolite of nicotine and 
is a biomarker for active and passive smoking. To adequately distinguish smokers from 
nonsmokers a cotinine level cut point of 3 ng/ml has been recommended 141.  In this 
study, participants were considered smokers if they had a serum cotinine level of greater 
than 3 ng/ml and a nonsmoker if 3 ng/ml or less. 
3.2.8. Sexual behavior 
Self-reported data on sexual behavior was obtained through ACASI in the MEC. 
Questions assessed whether participants had ever had sex, the age they first engaged in 
sex, and type of sex (anal, oral or vaginal). Questions were also asked about both 
lifetime and past year partners, whether partners were same or opposite sex, and specific 
same sex partner questions for both men and women. Several additional detailed 
questions were included in the self-reported survey, but due to non-response and 
missingness on those questions a subset of selected questions were used. Questions of 
interest include age at first sex, ever performed oral sex, ever performed anal sex, 
number of sex partners 5 years or older than the subject, number of sex partners in the 
past year, number of times subjects engaged in sex without a condom, and whether men 






3.2.9. Statistical Analysis  
Exploratory and univariate analyses were conducted to determine the distribution 
and frequency of each variable. Due to the NHANES design, variables are weighted to 
account for oversampling, nonresponse in the survey, and the probability design 
following the guidelines provided in the survey documentation 136. Principal component 
analysis 142  was performed on variables that were similar indicators of socioeconomic 
status and sexual risk behaviors to reduce potential multicollinearity issues. Analyses 
were stratified by sex due to the differences in sexual risk indicators for both males and 
females 39 61 143.  Indicators for each measure included a score of 10 or more on the PHQ-
9 to suggest depression, reporting at least 1 alcoholic beverage per day, ever using any 
illicit drug, having a sexual debut younger than 15 years old, reporting ever having oral 
or anal sex, having any partners that were 5 years or older than the individual, and 
reporting ever having sex without a condom. 
Composite variables were created from each of these individual indicator 
variables. A new indicator was created to signify the presence of the variable (e.g., if 
depression was present, depression=1, if no depression, depression=0) then the 
indicators were summed to create a composite variable “syndemic score”. Scores were 
assigned to depression, regular alcohol use, any drug use including marijuana, smoking, 
and the presence of sexual behavioral risk factors. A composite range of 0-9 was 
established based on the number of reported syndemics for each group. The frequencies 
and percentages of the syndemics were calculated, and then PROC LOGISTIC in SAS 




the syndemic score and STI.  Common sociodemographic indicators associated with STI 
risk are young age, race/ethnicity other than white, and indicators of low socioeconomic 
status 144. Principle component analysis was conducted using each of the 
sociodemographic indicators to determine highly correlated variables. Among the highly 
correlated variables, one was chosen for regression. Therefore, regression models were 
adjusted for race, country of birth, poverty index ratio (PIR), number of people living in 
household, and the head of household country of origin, education level, and marital 
status. Odds ratios (OR), adjusted odds ratios (AOR) and 95% confidence intervals (CI) 
are reported. 
LCA for men and women were performed using PROC LCA version 1.3.2, SAS 
V9.4, Cary NC 145. All analyses incorporated sample weights. Model selection was 
achieved by examining common measures of model fits including the G2 likelihood ratio 
chi square test, the Akaike Information Criterion (AIC), Bayesian Information Criterion 
(BIC) and entropy to compare models 128.  In each of these criteria, with the exception of 
entropy, lower values suggest optimal parsimony and model fit. Entropy is a measure of 
the model’s ability to separate clusters. An entropy approaching 1 is an indicator of 
better separated classes which delineate from each other and suggests a better fitting 
model 146.  Missing data were handled with the maximum likelihood expectation 
maximization procedure and assumed to be missing at random in PROC LCA. The 
association between class membership and STIs was obtained using logistic regression. 
Odds ratios (OR), adjusted odds ratios (AOR) and 95% confidence intervals (CI) are 





3.3.1. Descriptive results 
The composition of the sample was relatively diverse in age (mean: 21.1, SD: 
2.4) and race (32% Non-Hispanic White, 26% Non-Hispanic Black, 25% Hispanic, 12% 
Asian, and 5% other) as described in Table 3.1. Roughly, 30% reported a head of 
household that was foreign born, 36% reported a head of household with some college 
education, and 58% had unmarried heads of household. STI positivity was 9% (HIV-
0.12%, HSV-5.6%, Chlamydia-4.6%), the prevalence of depression was 7%, regular 
alcohol use was 44%, and smoking was 29%. Ever using marijuana was 42% and ever 
using cocaine, heroin, or methamphetamine was 8%. Majority of the sample reported 
ever engaging in oral sex (68%) and inconsistent condom use (76%), while smaller 
proportions reported anal sex (27%), older partners (30%), and more than 1 partner in 





Table 3.1. Demographic characteristics for sample of young adults 2011-2014, N=1803. 
Variable/Label  N (%) Mean (SD) Missing (n) 





Age 18-25  21.1 (2.36)  
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Serum cotinine level < 3 or 
> 3 
Nonsmoker (< 3) 
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a woman or a man (male 










Table 3.1. Demographic characteristics for sample of young adults 2011-2014, N=1803, 
Continued 
Variable/Label  N (%) Mean (SD) Missing 
(n) 
Number of sex partners 5 







# of sex partners in the past 








Number of times you had 































3.3.2. Composite scores 
The mean number of reported indicators was 2.3 (SD: 2.4) among the sample. 
The odds of a positive STI result increased with the number of indicators. The gender-
specific analysis is shown in Table 3.2, and suggests males reporting 3-5 indicators 
(35.9%) (AOR: 2.10 CI 95% 1.0-4.2) and six or more indicators (13%) (AOR: 2.84 CI 
95% 1.2-6.7) had a significantly increased odds of STI after adjustments. Females had a 
significantly increased odds of STI when they reported six or more indicators (11.0%) 









Table 3.2. Association of interrelated social and behavioral categories (syndemic) and 
STI positivity among males and females 18-25, NHANES 2011-2014. 
 
Number of social and 
behavioral indicators 
present (N, %) 
STI positive 
 Unadjusted odds 
ratio (95% CI) 
p-values Adjusted odds ratio*  
(95% CI) 
p-values 
Males      
0-2 (464, 51.10%) 
reference 
-- -- -- -- 










Females      
0-2 (490, 54.75%) 
reference 
-- -- -- -- 










Social/behavioral indicators include depression, regular alcohol use, smoking, ever using drugs, age 
at first sex, any anal or oral sex in the past year, any partners 5 years or older in the past year, 
greater than 1 partner in the past year, and ever sex without a condom in the past year. 
Bolded values indicate p < 0.05. 
*Adjustments are for demographic characteristics listed in Table 1. (race, country of birth, PIR, 





No other significant relationships were observed from the composite score analysis. 
3.3.3. Latent Class Analysis 
A four class model was selected for males and a three class model for females. 
Models were selected if they showed the greatest distinction between classes and 













Table 3.3. Fit statistics for LCA model selection in men and women age 18-25, NHANES 2011-2014. 









AIC BIC Entropy  
Men N=908 1 -4649.05 1352.46 1013 1372.46 1420.57 1.00 
 2 -4382.38 819.12 1002 861.12 962.16 0.64 
 3 -4294.08 642.53 991 706.53 860.49 0.68 
 4* -4257.10 568.55 980 654.55 861.44 0.71 
 5 -4223.87 502.10 969 610.10 869.90 0.67 
 6 -4205.61 465.58 958 595.58 908.31 0.70 
        
Women 
N=895 
1 -4553.41 1325.23 1013 1345.23 1393.19 1.00 
 2 -4303.49 825.38 1002 867.38 968.11 0.62 
 3* -4217.20 652.80 991 716.80 870.30 0.65 
 4 -4204.44 627.27 980 713.27 919.53 0.63 
 5 -4176.46 571.33 969 679.33 938.35 0.69 
 6 -4167.17 552.73 958 682.73 994.52 0.80 
        
*Indicates selected model  
Model selection was achieved by examining the G2 likelihood ratio chi square test, the Akaike 
Information Criterion (AIC), Bayesian Information Criterion (BIC) and entropy. With the exception of 
entropy, lower values suggest optimal parsimony and model fit. The BIC and entropy were used for 
model selection in both sexes as the AIC favored more complex models. After reviewing the models 




Table 3.4 shows class membership probabilities for men. Class one (28%) was 
the second largest class and reported the least indicators of any group; class one was 
used as the reference class in the regression models. Class two (15%) indicated the 
highest proportion of men who had partners that were 5 years or older (38%), but 
reported a lower probability of other indicators. Participants in class three (37%), the 
largest class in men, reported the highest proportion of smoking (61%), oral (98%) and 
anal sex (58%), reported two or more partners in the past year (64%), and had the 




had the highest probability of reporting depression (8%), regular alcohol use (71%), 
early sexual debut (86%), and ever using any drugs (96%). When compared to class one, 
males in class three had significantly increased odds of STI (AOR: 2.42 CI 95% 1.1-5.4) 
after adjustments. No other associations were found among men and no co-occurring 




Table 3.4. Class membership (%) and probability of response in male (n=908) participants age 18-25, 
NHANES 2011-2014.  









Depressed  0.0135 0.0595 0.0600 0.0766 
Regular alcohol 
use 
0.3675 0.3500 0.1699 0.7103 
Smoker  0.1232 0.3778 0.6097 0.0000 
Age at first sex 
< 15 
0.1798 0.5222 0.6352 0.8642 
Oral sex  0.9176 0.0000 0.9776 0.0000 
Anal sex 0.1992 0.0296 0.5822 0.0071 
Partners 5yr + 0.0777 0.3809 0.3701 0.0510 
2 + partners  0.2319 0.0961 0.6429 0.0000 
Inconsistent 
condom 
0.7277 0.5590 0.8567 0.5983 
Ever used any 
drug  
0.4519 0.1806 0.0804 0.9572 
     
Odds of STI (reference) Class 2 vs class 1 
OR=1.65 
(CI 95% 0.6-4.2) 
*ORadj=1.62 
(CI 95% 0.6-4.4) 
Class 3 vs class 1 
*¥OR=2.96 
(CI 95% 1.4-6.1) 
*¥ORadj=2.42 
(CI 95% 1.1-5.4) 
Class 4 vs class 2 
OR=0.14 
(CI 95% 0.02-1.1) 
*ORadj=0.17 
(CI 95% 0.02-1.4) 
*Adjustments are for demographic characteristics listed in Table 1. (race, country of birth, PIR, 
number of people living in household, and head of household country of origin, education level, and 
marital status). 







Membership probabilities and class composition for women are shown in Table 
3.5. Class one (37%) was the largest class and was comprised of women reporting a low 
probability of each of the indicators, which was used as the reference class for 
regression. Among women in class two (33%), regular alcohol use (73%) and early 
sexual debut (68%) were the highest reported probabilities. Class three (29%) reported 
the highest conditional probability of depression (23%), smoking (61%), oral sex (99%), 
anal sex (55%), older partners (42%), two or more partners in the past year (49%), 
inconsistent condom use (86%) and any drug use (86%). Women in this class seemed to 
exhibit a syndemic of depression, smoking, drug use and sexual risk behaviors. In 
reference to class one, women in class three had a significantly increased odds of STI 
(AOR: 2.19 CI 95% 1.2-3.8) after adjustments. No other significant associations were 
found among women. Class three indicates a possible syndemic of depression and 





Table 3.5. Class membership (%) and probability of response in female (n=895) participants age 
18-25, NHANES 2011-2014.  




Class 3  
(n=322, 35.91%) 
Depressed  0.0415 0.0425 0.2332 
Regular alcohol use 0.6513 0.7268 0.3969 
Smoker  0.0156 0.1135 0.6085 
Age at first sex < 15 0.8015 0.3198 0.4462 
Oral sex  0.9768 0.1527 0.9859 
Anal sex 0.3440 0.0000 0.5536 
Partners 5yr + 0.1717 0.3532 0.4254 
2 + partners  0.2066 0.0228 0.4858 
Inconsistent condom 0.7991 0.6465 0.8654 
Ever used any drug  
(including marijuana) 
0.5553 0.7725 0.0818 
    
Odds of STI (Reference) Class 2 vs class 1  
OR= 1.27 
(CI 95% 0.75-2.15) 
*ORadj=1.49 
(CI 95% 0.80-2.77) 
Class 3 vs class 1 
OR= 2.65 
(CI 95% 1.63-4.31) 
*ORadj= 2.31  
(CI 95% 1.32-4.05) 
*Adjustments are for demographic characteristics listed in Table 1. race, country of birth, pir, 
number of people living in household, and head of household country of origin, education level, 





 Understanding syndemic factors for sexually transmitted infections is particularly 
important in late adolescents and early adulthood. In 2008, A US evaluation of the 
prevalence of STIs determined that women age 15-24 represented an estimated 660,000 
cases of chlamydia 8 and that rates varied by race/ethnicity indicating the persistence of 
disparities 147.  Few studies have used nationally representative data to examine 
appropriate statistical measures to identify syndemics for recommending widespread 
prevention activities.  
 In our study we sought to examine common statistical approaches to identify 




approach, we found that as the syndemic score increased so did the odds of STI in men, 
but was only increased for women reporting six or more indicators. This method 
suggests that as the number of risk factors increase the odds of STI also increase. A 
syndemic scoring approach may reveal risk related to multiple, simultaneously occurring 
conditions in a specific group. However, syndemic scoring methods are typically unable 
to determine the specific psychosocial factors related to increased risk of infection 
among certain groups.  
In this study, the syndemic scoring method did not reveal any differences in the 
social and behavioral indicators for men and women therefore did not reveal any useful 
information related to the conditions of the individuals at increased risk of STI. Similar 
to this study, a cross-sectional survey of 300 male sex workers in Vietnam used a 
syndemic scoring method to identify a syndemic related to unprotected anal sex, a sexual 
behavioral indicator that increases the risk of HIV 119.  The findings suggested that a 
higher syndemic score included psychosocial conditions that increased the risk of HIV 
acquired through unprotected anal sex among male sex workers. However, the specific 
needs of those sex workers were undetermined because the syndemic score was unable 
to reveal the prevalence of the psychosocial conditions that were co-occurring.   
Similarly, a cross sectional analysis of 2,020 men who have sex with men in 
Latin American determined that the presence of more psychosocial factors were related 
to being less likely to adhere to antiretroviral therapy 93. Again, a syndemic score that 




adherence, but did not result in specific indicators and how those indicators co-occur to 
increase the risk of negative drug adherence. 
 A latent class analysis was used in the present study to examined psychosocial 
indicators to determine which variables were co-occurring to increase the risk of STI. In 
men, the LCA revealed a class that consisted of co-occurrence of depression and 
substance use, but individuals in this group did not have increased risk of STI. Males 
with a higher probability of smoking and sexual risk behaviors were at increased risk of 
STI. A syndemic was not evident among men because the prevalent indicators were 
sexual behaviors which are known to directly increase STI risk. Among women, a 
syndemic of depression, drug use and smoking co-occurred with sexual risk behaviors to 
increase the risk of STI. This syndemic was particularly informative because it allowed 
the observation of specific characteristics of the women who were at increased odds for 
STI.  
Our study had similar findings to a longitudinal study of 4,158 high school 
sophomores, juniors, and seniors examining their risk for STI 135.  Authors determined 
classes at increased risk of STI also exhibited depressive symptoms and substance use. 
These results are useful in identify a target population, giving a specific understanding of 
the problems co-occurring with sexual risk behaviors, and can inform prevention efforts 
on how to formulate interventions to optimize effectiveness. For example, women from 
our study may need an intervention that addresses their mental health and coping 





Latent class analysis is particularly useful because of its limited number of 
assumptions, its’ person-centered approach, and its ability to allow multiple intersecting 
measured characteristics in the model when the population evaluated is hypothesized to 
have an underlying latent construct, such as syndemics 127. The greatest benefit of LCA 
is its ability to separate subjects into heterogeneous groups that identify similar reported 
indicators and risk of STIs.  
Additionally, structural equation models (SEM) have been suggested to examine 
syndemic pathways to increase STI risk. SEM are path analyses that allow for multiple 
indicators of latent constructs to estimate the linear relationship between the latent 
variables and indicator or observed variables 148. SEM was adopted as a robust analysis 
due to its ability to consider simultaneous models, endogenous and exogenous variables, 
and handle continuous, ordinal, dichotomous or censored variables149. In syndemics 
research, SEM has been used to determine the direct and indirect effects of indicators on 
syndemic latent variables in a number of subject areas. These include, discrimination 68, 
substance use 20 132, violence and depression 85 150 151, suicidality 152 and HIV and STI 
risk 153. SEM is an additional useful tool in understanding how variables are structured 
together and may be a useful alternative for providing information on the multiple linear 
relationships that may be present simultaneously on a syndemic pathway. 
While each of the models are useful, there are limitations. Syndemic scoring 
approaches tell little about the relationship between indicators and how they may interact 
to influence increasing risk. Furthermore, required assumptions are that the variables 




assumptions, but ignore some uncertainty that may arise in class predictions 122.  
Furthermore, latent class requires categorical formats for data, requiring the recoding of 
continuous variables that may lose their importance in a different format 127.  In this 
study, we included original categorical variables and included widely used and validated 
cut-points for continuous variables that were converted into categories. Some limitations 
to this study include the lack of the most recent NHANES data, which was not fully 
updated at the time of this analysis, the exclusion of “other” race groups (such as Asians) 
due to their small sample, and cross-sectional nature of this study design that limits 
inferences about timing of the syndemics found. 
3.5. Conclusion 
Identifying the most appropriate models for syndemic research is imperative when 
conducting analysis using population level data. Techniques need to be both statistically 
and qualitatively informative and provide robust estimates for both smaller and large 
samples. In this analysis, the latent class model provided the most robust estimates 
concerning risk for sexually transmitted infection and identified co-occurring indicators 
that may increase the risk of STI among a nationally representative sample of young 
adults aged 18-25. The findings suggest that scoring approaches give little to determine 
the presence of a syndemic, and do not produce information that can be useful in 
formulating interventions. Most importantly, the composite score shows that men need 
fewer and more behavioral risk factors to increase their risk of STI while women 
reporting a greater number of risk factors had an increased risk of STI. Latent class 




reporting those indicators among the group of individuals with them, and can be useful 
to detail problems that must be addressed in intervention development. Using techniques 
that are informative on heterogeneous groups can provide direct translation into practice 
for prevention strategies and can allow for social, environmental, and behavioral risk 
factors that influence STI risk to be addressed simultaneously. 
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4. EXAMINING RACIAL/ETHNIC PROFILES OF SEXUALLY TRASNMITTED 
INFECTION RISK IN YOUNG ADULTS USING A LATENT CLASS ANALYSIS* 
4.1. Introduction 
Adolescence and young adulthood are important periods for the development of 
intimate relationships and are characterized by risk behaviors such as unprotected sex, 
increasing rates of substance use, and the exacerbation of health and social disparities 15.  
These developmental periods are also associated with increased incidence of depression. 
For example, as many as one in five American adolescents suffers from a diagnosable 
depressive episode by age 18 154.  Substance use, social relationships, mental health, 
risky behavior and sexually transmitted infections (STIs) are highly interrelated 155.  
STIs have a significant public health impact as their effects range from reproductive 
sequelae (e.g. infertility) to chronic health conditions 156. Adolescents and young adults 
account for half of all new STIs in the United States making them an important group for 
risk reduction 156.  However, interventions that target known individual risk factors have 
not been successful in reducing STI rates or racial/ethnic and sex specific disparities in 
STIs 45.  
The development and progression of sexual behaviors and risk of STIs varies as a 
function of race/ethnicity and sex. For example, striking disparities exist in Chlamydia 
trachomatis prevalence with Hispanic and Black women having much higher rates than 




factors 157.  Significant disparities exist between sexes in the development of substance 
use, STI/HIV risk behaviors, STI/HIV transmission and reproductive health outcomes. 
Sex and racial/ethnic differences in risk behavior also persist. For instance, females tend 
to have fewer sex partners and report less binge-drinking but have a higher risk of STIs 
than males 143.  Risk behaviors may also interact differently as a function of 
race/ethnicity and sex. For example, rates of receptive anal sex are positively related to 
binge drinking in females but not males 158.  Black females are less likely to report high 
risk behaviors (e.g. lifetime partners, unprotected sex, substance use) but are consistently 
more likely to test positive for STIs 61.  
Traditional disease control programs with singularly focused interventions 
neglect broader perspectives 63  and are insensitive to marginalized experiences that 
contribute to poor sexual health 78.  Syndemic theory suggests that the convergence of 
social, environmental and ecological factors often produce difficult environments that 
promote disease 159. Understanding the syndemics of STIs in adolescents and young 
adults may provide a unique opportunity to develop effective and culturally appropriate 
interventions that target high risk, hard to reach groups.  The syndemics literature has 
overwhelmingly focused on HIV in men who have sex with men (MSM) or sexual 
minorities, and have not considered effect modification by sex or race/ethnicity 66 160. 
Furthermore, these studies have misclassified syndemics with the use of syndemic 
scoring methods. The objective of this study is to use latent class analysis (LCA), a type 
of finite mixture modeling approach that identifies subgroups based on observed 




a large, nationally representative dataset. It is hypothesized that the co-occurrence of 
multiple risk categories will increase the probability of STIs and are unique to groups 
defined by sex and race/ethnicity. 
4.2. Methods 
4.2.1. Study population 
This was a cross-sectional analysis of individuals aged 18-25 interviewed in the 
National Health and Nutrition Examination Survey (NHANES) in waves 2011-2012 and 
2013-2014. NHANES is a multistage probability survey with complex design to be 
representative of the general United States population 136.  Data collection methods are 
explained elsewhere 136.  We excluded subjects without a determinant STI test result (see 
below for description of STIs) (n=236), resulting in a sample of 1,664 participants with 
complete data.  
4.2.2. Demographics 
This study focused on white, non-Hispanic black, and Hispanic individuals 
because the samples were large enough to use LCA with subgroup analysis of risk for a 
positive STI test. Other demographics of interest were number of people living in the 
household (1-4 or 5+), country of birth of the head of household (US or other), poverty 
index ratio (< 1.3), head of household education (high school graduate or less), and head 
of household marital status (unmarried).  
4.2.3. Sexually Transmitted Infections  
Urinary and serum blood samples were used for laboratory analysis and 




(HSV-2) were diagnosed by nucleic acid amplification test (NAAT) and HIV was 
diagnosed through synthetic peptide enzyme immunoassay (EIA) 101.  A composite 
variable for STI was created if subjects were positive for any of the STIs (Chlamydia 
trachomatis, Herpes Simplex Virus II, or HIV).  
4.2.4. Mental health 
Mental health was assessed using the 9-item Patient Health Questionnaire (PHQ-
9). The PHQ-9 is a widely used and well-validated screener of depression severity and 
symptoms in youth 138.  There were 9 questions assessing depressive symptoms in the 
two weeks before the survey with four response categories (0-3) denoting the occurrence 
and frequency of depressive symptoms. These were summed for an overall score ranging 
from 0 to 27 139.  A score of 10 or greater is considered the threshold for depression, and 
was used as the cut point in this study 139.  
4.2.5. Illicit drug use 
The drug use questionnaire (DUQ) administered through the NHANES was used 
to assess past year use of marijuana or hashish, cocaine, heroin, and methamphetamine. 
Due to non-response and missingness in the more detailed questions, these ever use 
questions were used in this analysis.  
4.2.6. Alcohol use 
The alcohol use questionnaire assessed frequency of alcohol consumption in the 
past year. Participants were classified into one of three alcohol use groups: (1) 
abstainers, those who had less than 12 drinks in their lifetime; (2) moderate alcohol 




day; and (3) excessive alcohol users, men who have 5 or more drinks in one day or 
women who have 4 or more drinks in one day 140.  
4.2.7. Smoking status 
 Cotinine is the primary metabolite of nicotine and is a biomarker for active 
and passive smoking. To adequately distinguish smokers from nonsmokers a cotinine 
level cut point of 3 ng/ml was recommended 141.  In this study, participants were 
considered smokers if they had a serum cotinine level of greater than 3 ng/ml and a 
nonsmoker if 3 ng/ml or less. 
4.2.8. Sexual behavior 
Participants were asked if they had ever had sex, the age they first engaged in 
sex, and what type of sex (anal, oral or vaginal) via audio-computer-assisted self-
interview (ACASI). Additional questions included number of partners, times subjects 
engaged in sex without a condom, and whether the male subjects were circumcised.   
4.2.9. Statistical Analysis 
LCA was used to identify syndemics profiles of demographic characteristics, 
mental health, substance use, and sexual risk behaviors among 18 to 25 year old’s in the 
NHANES. A total of 18 variables were included in the LCA to determine syndemic 
patterns by race/ethnicity among each gender. Measurement invariance was imposed to 
test whether the latent classes were similar or different across gender. In this sample, 
measurement invariance did not hold because the difference between the freely 
estimated model and the constrained model displayed significant differences in 




each sex. All analyses were performed in SAS software (Version 9.4, Cary, NC). The 
LCA was completed using the LCA Procedure, version 1.3.2 145.  All analyses 
incorporated sample weights to account for NHANES survey design. Model selection 
was achieved by examining common measures of model fit including the G2 likelihood 
ratio chi square test, the Akaike Information Criterion (AIC), Bayesian Information 
Criterion (BIC) and entropy 127.  On each of these criteria, with the exception of entropy, 
lower values suggest optimal parsimony and model fit. Multiple groups LCA were run 
by race (white, non-Hispanic black, and Hispanic) to test differences between groups. 
Race was added as a grouping variable and fit statistics were compared to determine 
appropriate model fit. The association between class membership and STIs was 
estimated for each sex using logistic regression. Odds ratios (OR) and 95% confidence 
intervals (CI) were calculated.  
4.3. Results 
4.3.1. Descriptive results 
STI positivity was 11% in the sample (HIV= 1.2%, CT=5.0%, HSV-2=5.6%). 
Roughly 7% reported depression, 8% excessive alcohol use, and 31% were smokers. The 
majority of participants reported engaging in oral sex (68%), while only 28% indicated 
anal sex. Two-thirds had not used a condom during sex at least once in the past year, 
30% had a partner who was five years or older, and 30% had greater than two sex 
partners in the past year. The majority of participants reported marijuana use (58%), 





4.3.2. Latent classes by race 
To address known racial disparities in STI risk, multiple-group LCA was 
conducted by race in each sex group separately. Three class solutions were selected as 
they provided enough distinctions between the classes, retained an adequate sample size 




Table 4.1. Fit statistics for LCA model selection in females and males. 









AIC BIC Entropy  
Female N=830 1 -7028.84 4418.42 131054 4452.42 4532.68 1.00 
 2 -6703.97 3768.66 131036 3838.66 4003.91 0.68 
 3* -6617.86 3596.45 121018 3702.45 3952.69 0.68 
 4 -6585.26 3531.24 131000 3673.24 4008.46 0.71 
 5 -6548.31 3457.35 130982 3635.35 4055.56 0.68 
 6 -6510.35 3381.44 130964 3595.44 4100.63 0.74 
 7 -64.96.60 33.54.53 130946 3604.53 4194.71 0.71 
Male N=834        
 1 -7609.60 5397.32 262125 5433.32 5518.40 1.00 
 2 -7245.38 4668.89 262106 4742.89 4917.76 0.70 
 3* -7138.44 4455.00 262087 4567.00 4831.67 0.70 
 4 -7054.28 4286.68 262068 4436.68 4791.15 0.70 
 5 -7003.11 4184.35 262049  4372.35 4816.61 0.72 
 6 -6964.40 4106.93 262030 4332.93 4866.99 0.74 
 7 -6907.00 3992.14 262011 4256.14 4880.00 0.76 
*Indicates selected model  
Model selection was achieved by examining the G2 likelihood ratio chi square test, the Akaike 
Information Criterion (AIC), Bayesian Information Criterion (BIC) and entropy. With the 
exception of entropy, lower values suggest optimal parsimony and model fit. The BIC and entropy 
were used for model selection in both sexes as the AIC favored more complex models. After 





Profiles in women by race varied (Table 4.2). White women in class 1 (high risk) 




smoking and depression. Class 2 white women reported the lowest chance of risky 
sexual behavior, and primarily reported regular alcohol use with very little drug use. 
Class 3 reported some risky sexual behaviors, and drug use. Young white women in 
class 1 had a nearly tenfold increase in their odds of STI (OR=2.9 95% CI 1.3-27.2) 
when compared to the low risk class (class 2, reference). No other associations were 
found. 
Class 1 in black young women was considered the high risk profile and contained 
low income indicators, a high chance of reporting depression, excessive alcohol use and 
smoking (Table 4.2). In class 2, women reported similar demographics as class 1, but 
lower risky sexual behaviors and regular alcohol use. Class 3 contained black women 
with unmarried head of households, sexual risk behaviors and some marijuana use. 
Interestingly, none of the classes in black women reported any illicit drug use. Compared 
to low-risk white young women (class 2), black young women in class 1 had a 
significantly increased odds of STI (OR=9.9 95% CI 2.1-46.3). No other associations 
were found. 
Among Hispanic young women there was a high chance of being low income 
across all classes. Class 1 included the highest chance of risky sexual behaviors with 
some low income characteristics. Class 2 included Hispanic women with low income 
(Table 4.2). Class 3 contained low income, high chance of risky sexual behavior, and 
illicit drug use. When compared to white women in class 2 (referent group), Hispanic 







Table 4.2. Latent class membership and probabilities (%) for syndemic indicators in females by race, NHANES 2011-2014.  
(adapted from 161)  
Race                                                                            White, n=250 Black, n=234  Hispanic, n=223 
Item/Variable Class 1 
(28.88%, 
n=72) 
























5+ in house 0.2383 0.1933 0.1950 0.2536 0.3669 0.0756 0.0282 0.4591 0.4662 
HS grad or less 0.3622 0.2771 0.3491 0.6416 0.4928 0.0934 0.7068 0.6806 0.4985 
PIR low-income 0.4894 0.3045 0.3698 0.8087 0.5432 0.5156 0.6959 0.5672 0.6240 
HH Country non-US 0.0000 0.1062 0.0850 0.0258 0.1074 0.0671 0.3330 0.6574 0.5535 
HH unmarried 0.7643 0.4508 0.5003 0.8326 0.6284 0.9808 0.9040 0.4409 0.5657 
Depressed  0.2971 0.0927 0.0757 0.2577 0.0404 0.0231 0.4116 0.0099 0.0612 
Regular alcohol use 0.4566 0.8064 0.4209 0.4366 0.7513 0.4735 0.0000 0.6202 0.4956 
Excessive alcohol use 0.1615 0.0000 0.0000 0.2420 0.0105 0.0549 0.1850 0.0178 0.0000 
Smoker  0.8241 0.1120 0.0844 1.0000 0.1023 0.0690 0.6351 0.0415 0.0266 
Age at first sex < 15 0.5856 0.4875 0.1790 0.5984 0.2945 0.6146 0.5396 0.3104 0.5658 
Oral sex  1.0000 0.3774 1.0000 0.8181 0.5373 0.9502 1.0000 0.5031 1.0000 
Anal sex 0.6181 0.0000 0.4729 0.3068 0.0992 0.5055 0.4436 0.0257 0.9576 
Partners 5yr + 0.5308 0.2581 0.1254 0.4261 0.4047 0.3243 0.4856 0.2515 0.3751 
2 + partners  0.5112 0.0000 0.2838 0.4259 0.1761 0.7159 0.5985 0.0818 0.0757 
Inconsistent condom 0.9109 0.6943 0.7680 0.9569 0.7254 0.9022 0.6757 0.7119 0.9056 
Ever used marijuana 0.9690 0.1685 0.6132 0.8917 0.3670 0.8771 0.8640 0.2955 0.6426 
Ever used illicit drugs 0.3083 0.0000 0.0451 0.0000 0.0000 0.0000 0.0727 0.0000 0.2027 
          
Odds of STI White class 1 vs white class 2 (ref) 
OR=2.9 (CI 95% 1.3-27.2) 
Black class 1 vs white class 2 (ref) 
OR=9.9 (CI 95% 2.1-46.3) 
Hispanic class 1 vs white class 2 
(ref) OR=9.5 (CI 95% 1.8-51.3) 
  Black class 1 vs black class 2 (ref) 
OR=1.04 (CI 95% 0.51-2.1) 
Hispanic class 1 vs Hispanic class 






Of note, when compared to Hispanic women in class 2, class 1 had a four fold 
increase in their odds of STI (OR=4.2 95% CI 1.4-12.8) and had the lowest chance of 
reporting foreign-born head of households when compared to class 2 and 3. No other 
associations were found. 
Within group differences were less varied among males, and no class of white or 
Hispanic males were at greater risk of a STI (Table 4.3). White males in Class 1 were 
most sexually risky, class 2 included a higher chance of regular alcohol use and early 
sexual debut, and class 3 included men with unmarried head of households. None of 
these classes were associated with increased odds of an STI.  
Class 1 black males included a higher chance of risky sexual behaviors and low 
income. Black males in class 2 had head of households that were less educated and 
reported a higher chance of regular alcohol use. Class 3 black males reported the least 
risky sexual behaviors (Table 3). Young black males from class 3 had over a sixteen fold 
increase in their odds of STI compared to white males (OR=16.4 95% CI 3.7-72.0), but 
not when compared to lower risk black males in class 2 (OR=1.5 95% CI 0.4-4.8). 
Hispanic males in class 1 had the highest chance of reporting low income 
indicators and risky sexual behaviors along with excessive alcohol and illicit drug use 
(Table 4.3). Class 2 contained males with low income indicators, but a low chance of 
reporting risky sexual behaviors, and class 3 included males with some risky sexual 
behaviors and illicit drug use. None of these classes were associated with increased odds 






Table 4.3. Latent class membership and probabilities (%) for syndemic indicators in males by race, NHANES 2011-2014.  
(adapted from 161)  
Race                                                                            White, n=250 Black, n=234  Hispanic, n=223 
Item/Variable Class 1 
(37.97%, 
n=106) 
























5+ in house 0.2040 0.5182 0.1378 0.1805 0.8488 0.0842 0.4012 0.5667 0.2353 
HS grad or less 0.3368 0.0808 0.2688 0.4894 0.6260 0.2029 0.8202 0.6793 0.1781 
PIR low-income 0.4930 0.1527 0.2677 0.4548 0.3147 0.5875 0.7003 0.5211 0.1511 
HH Country non-US 0.0000 0.0950 0.0174 0.0182 0.3525 0.0804 0.7657 0.7340 0.1615 
HH unmarried 0.6873 0.1554 0.5650 0.7658 0.2652 0.8503 0.5649 0.4477 0.5614 
Depressed  0.0499 0.0866 0.0092 0.0371 0.0000 0.1108 0.0856 0.0406 0.0191 
Regular alcohol use 0.1013 0.8595 0.3110 0.3744 0.9066 0.6250 0.0548 0.4295 0.3617 
Excessive alcohol use 0.2319 0.0578 0.0000 0.1413 0.0000 0.0233 0.2271 0.0000 0.0000 
Smoker  0.6181 0.0186 0.2293 0.8612 0.3989 0.1971 0.5081 0.0576 0.3128 
Age at firs sex < 15 0.5726 0.7093 0.1666 0.7059 0.6186 0.3456 0.5294 0.2666 0.6697 
Oral sex  0.9930 0.2028 0.6996 0.9254 0.2991 0.5621 0.8819 0.4416 0.8232 
Anal sex 0.6191 0.0152 0.1591 0.3606 0.0769 0.1775 0.5018 0.0966 0.5719 
Partners 5yr + 0.3002 0.3058 0.0308 0.4687 0.5511 0.2626 0.4273 0.1935 0.1120 
2 + partners  0.6482 0.0847 0.1000 0.6874 0.4217 0.2637 0.6387 0.0910 0.3823 
Inconsistent condom 0.8902 0.2818 0.8109 0.8178 0.3726 0.7599 0.7332 0.5825 0.9415 
Uncircumcised 0.1481 0.1952 0.0000 0.2004 0.4275 0.2516 0.6026 0.6847 0.4120 
Ever used marijuana 0.8941 0.2489 0.6133 0.9884 0.7739 0.4511 0.9119 0.3304 0.8311 
Ever used illicit drugs 0.2859 0.0000 0.0105 0.0268 0.0000 0.0015 0.2579 0.0000 0.2219 
          
Odds of STI White class 1 vs white class 3 
(ref) OR=1.3 (CI 95% 0.2-8.1) 
Black class 1 vs white class 3 
(ref) OR=16.4 (CI 95% 3.7-
72.0) 
Hispanic class 1 vs white class 3 
(ref) OR=3.3 (CI 95% 0.62-17.3) 
  Black class 1 vs black class 2 
(ref) OR=1.5 (CI 95% 0.4-4.8) 
Hispanic class 1 vs Hispanic class 






Improving sexual health in young adults is a public health goal 162 but 
interventions that are effective at reducing STIs in this group are limited 160.  There has 
been increasing interest in syndemic theory to provide a holistic approach to developing 
public health initiatives to reduce STIs 163.  The results of this study support a syndemic 
in young women that involves low income indicators, substance abuse and sexual 
behaviors that co-occur to increase risk for STI. Classes identified as high-risk for STI 
were characterized by substance use and depression, highlighting the importance of 
addressing mental health issues early in life.   
Race/ethnicity and sex are crucial factors in the development and exacerbation of 
social disadvantage 62.  Across all racial groups, women reported a higher probability of 
an unmarried head of household, even among low-risk profiles. High risk profiles for 
Hispanic and Black women had exceedingly high rates of STIs and different patterns of 
risk exposure compared to high-risk profiles for white women. Similarly, the chance of 
reporting depression was high among all high-risk profiles stratified by race and 
ethnicity in women, a finding confirmed by Senn et al. when examining syndemics in 
patients at an urban STD clinic 164.  High risk Hispanic women were lower income and 
reported greater proportions of uneducated, US born and unmarried head of households. 
Foreign-born head of household was protective for Hispanic young women, consistent 
with many studies of health among Hispanic Americans, including those focusing on 




High-risk profiles in Black women were characterized by low income and 
unmarried head of households, but risk behaviors did not differ greatly compared to high 
risk white and Hispanic young women. Black young women in the high-risk profile 
reported a lower proportion of anal and oral sex than white and Hispanic high risk 
women, but still had the highest odds of STI, consistent with previous findings 62.  Thus, 
targeting specific individual sexual risk behaviors may not decrease STIs in Black 
women. Based on the syndemic approach, interventions for Black women must include 
more than behavioral risk reduction, and should focus more on environment, social 
engagement, and access to resources.   
This study goes beyond individual STIs risk factors to classify the co-occurrence 
of those factors among different groups (i.e. syndemics) using a national representative 
sample with biological confirmed data. Syndemics have been studied in the context of 
substance use, violence and HIV risk behavior 159 but generalizability is an important 
limitation of that literature.  
Some limitations persist in this analysis. More recent NHANES data (NHANES 
2015-2016) was not available at the time of this analysis. The sample of “other” race 
groups (such as Asians) was too small for sensitivity analysis. Temporality may be an 
important factor in the development of syndemics, but this cannot be established using 
cross-sectional data. Some complexities of the sampling design of NHANES, such as a 
stratification and cluster variables, are not completely accounted for in the LCA 




and mid-adolescence are important developmental periods that need to be examined but 
NHANES data on STIs for participants age less than 18 are not available for public use.  
4.5. Conclusion 
Interventions to reduce STIs among young adults need to be culturally 
appropriate and tailored to specific groups. As reported in many other studies, Black 
women had increased risk of STIs even when reporting less risk behaviors. In contrast, 
high-risk men reported many risky behaviors that are the target of standard STIs 
prevention efforts. This suggest that traditional STI interventions focused on sexual 






The purpose of this dissertation was to identify profiles of risk for STI’s among 
young adults in the context of psychosocial perspectives using a syndemic framework. In 
the studies presented in this dissertation, syndemics were identified among a nationally 
representative sample of young women using a latent class analysis. Further race/ethnic 
analysis revealed additional syndemic indicators among young minority women.  
Additionally, this dissertation also examined chlamydia associated pregnancy 
outcomes in a population of primarily minority pregnant women revealing differences in 
outcomes by maternal age. Overall, these studies contribute to the literature through 
utilizing LCA, a statistically informative method, to identifying syndemics among 
minority women and to examine potential outcomes related to STIs during pregnancy for 
young minority women.  
Chapter 2 examined a population of primarily minority women and their risk for 
chlamydia associated adverse birth outcomes. Results suggested an association between 
Chlamydia trachomatis and medically indicated preterm birth among young women, but 
not other preterm birth subtypes. A significant relationship was found between C. 
trachomatis and term preeclampsia among Black and older women. This finding may 
suggest that untreated chlamydia infections may trigger global inflammatory responses 
eliciting preeclampsia in a later pregnancy. Although further confirmation is needed with 
complete previous infection history, this could be a vital support for age and race/ethnic 
specific screening among younger women and subsequent confirmatory test of cure. 




understand the relationship between preeclampsia and chlamydia. A racially diverse 
longitudinal pregnancy cohort would be beneficial in confirming these findings and best 
informing chlamydia prevention in pregnant women. Including more behavioral risk 
information would also allow the use of a syndemic approach and the development of 
risk profiles for a chlamydia related pregnancy outcome. 
To better understand the most useful methods to identifying syndemics, a 
comparison of syndemic scoring analysis and LCA was conducted in Chapter 3. Results 
reveal that scoring analysis to determine syndemics were unable to identify specific 
psychosocial indicators associated with increased risk of STI, how the indicators 
interacted or co-occurred, nor distinguished any differences in indicators between men 
and women. The syndemic scoring analysis lacked useful information related to the 
circumstances that may increase STI risk, making it difficult to translate findings into 
population level interventions.  In contrast, the models from the LCA provided more 
informative results by determining the exact indicators that co-occurred, and the 
prevalence of reporting those indicators among risk classes. A syndemic of depression 
and smoking co-occurred with sexual risk behaviors to increase the risk of STI among 
young women was found. Furthermore, the LCA showed distinct differences in 
indicators related to STI between men and women.  As women were determined to have 
syndemic profiles, next steps will include collection of longitudinal data on early 
adolescence into adulthood to examine the timing and onset of syndemics in young 




Chapter 4 utilized LCA to classify the co-occurrence of the psychosocial 
syndemic factors among different race/ethnic groups, which resulted in several 
interesting findings. A syndemic of poverty indicators, depression, excessive alcohol use 
and smoking was associated with increased risk of STI in Black women, while poverty 
indicators, sexual risk behaviors, and illicit drug use were associated with increased odds 
of STI in Hispanic women. Surprisingly, despite reporting fewer risky behaviors, Black 
women had increased odds of STIs. LCA identified these specific issues that 
complicated risk of STI for Black women. These finding suggest that traditional STI 
interventions focused on sexual behavior may not be beneficial for women, especially 
minority women. Interventions to reduce STIs among young adults need to be culturally 
appropriate and tailored to specific groups based on population level data. Future 
research should examine cohorts of Black and Hispanic women and collect data on their 
geographic surroundings to include in their syndemic profile. Including neighborhood 
level data is a novel approach to better understanding the specific needs of minority 
women based on their surroundings and will best inform prevention activities that will 
be specifically tailored to them to reduce morbidity. 
Some limitations must be noted from each of these analyses. In Chapter 2 and 3, 
examinations of NHANES data are limited in ability to establish temporality due to the 
cross-section design of the study. Also, data from the 2015-2016 and 2017-2018 waves 
were not complete or available and were not included for this analysis. Asian, 
multiracial, and individuals who identified as other were too small to conduct race/ethnic 




of NHANES (i.e., stratification and cluster variables) could not be accounted for in the 
LCA procedure in SAS, sample weights were included for the analyses presented in 
Chapters 2 and 3. A limitation of the final study was that the sample analyzed was 
primarily Hispanic from one geographic location. Despite the findings lacking 
generalizability to the larger population, the results suggest further investigation into 
race/ethnic specific perinatal outcomes associated with C. trachomatis are needed.  
Future research should address the aforementioned limitations. The studies in this 
dissertation found a syndemic among Hispanic and Black women, suggesting more in 
depth examinations of psychosocial indicators are needed.  Furthermore, incorporating 
additional psychosocial indicators in a perinatal cohort will greatly strengthen the 
understanding of adverse outcomes related to chlamydia infection. Future research 
should examine similar psychosocial indicators among younger individuals in mid-
adolescence (age 14-18), as this is important developmental period. Longitudinal 
evaluations should also be conducted to examine the timing of onset syndemics for 
young minority women.  
Overall, this dissertation provides greater insight to appropriate measures to 
understanding the risk of STI among a prevalent population and provide valuable 
information for health practitioner and researchers. Using LCA to examine the 
syndemics of sexually transmitted infections allows for the identification of specific 
psychosocial indicators that increase the odds of prevalent STIs among young adults. 
Identifying specific chlamydia associated pregnancy outcomes may facilitate an uptake 




findings may determine appropriate measures for evaluating populations at high risk and 
formulate prevention strategies that are targeted, culturally appropriate, and can be 
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Table A. Association between Chlamydia trachomatis and pregnancy outcomes in singleton pregnancies for Black women N=2,971, 
2011-2017   
Variable CT negative n (%) CT positive n (%) Model 1¥ Model 2 β Model 3± 
   RR (CI 95%) RR (CI 95%) RR (CI 95%) 
GA at delivery 
Term > 37 weeks (ref) 











Indicated PTB 129 (5.0%) 14 (7.2%) 1.46 (0.86-2.48) 1.77 (0.90-3.49) 1.72 (0.87-3.43) 














Term PE  84 (3.6%) 12 (7.2%) 2.0 (1.11-3.58) 2.50 (1.23-5.06) 2.46 (1.21-4.98) 














Modified Poisson regression with robust error measurements were used to calculate unadjusted relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for maternal age, foreign born status, marital status, education, insurance type, alcohol and gestational age at 
first prenatal visit 







Table B. Association between Chlamydia trachomatis and pregnancy outcomes in singleton pregnancies for White women 
N=3959, 2011-2017   
Variable CT negative n 
(%) 
CT positive n 
(%) 
Model 1¥ Model 2 β Model 3± 
   RR (CI 95%) RR (CI 95%) RR (CI 95%) 
GA at delivery 
Term > 37 weeks (ref) 3628 (96.7%) 36 (80.0%) -- -- -- 
Preterm < 37 weeks 286 (7.3%) 9 (20%) 2.74 (1.51-4.96) 2.40 (1.10-5.23) 2.30 (1.06-5.01) 
Indicated PTB 117 (3.1%) 5 (11.9%) 3.81 (1.64-8.84) 2.91 (0.98-8.60) 2.90 (0.97-8.66) 
Spontaneous PTB 77 (2.1%) 2 (5.1%) 2.47 (0.63-9.69) 3.24 (0.76-13.9) 3.12 (0.71-13.8) 
Preeclampsia (PE) 
Normotensive (ref) 3456 (95.9%) 39 (97.5%) -- -- -- 
Overall PE 147 (4.1%) 1 (2.5%) 0.61 (0.09-4.27) * * 
Term PE  66 (1.9%) 0 (0%) * * * 
Preterm PE 81 (2.3%) 1 (2.5%) 1.09 (0.16-7.65) * * 
Chorioamnionitis 
No (ref) 3743 (96.2%) 43 (97.7%) -- -- -- 
Yes 148 (3.8%) 1 (2.3%) 0.60 (0.09-4.17) 0.55 (0.08-3.84) 0.55 (0.08-3.54) 
Modified Poisson regression with robust error measurements were used to calculate unadjusted relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for maternal age, foreign born status, marital status, education, insurance type, alcohol and 
gestational age at first prenatal visit 







Table C. Association between Chlamydia trachomatis and pregnancy outcomes in singleton pregnancies for Hispanic women 
N=14,213, 2011-2017   
Variable CT negative n 
(%) 
CT positive n 
(%) 
Model 1¥ Model 2 β Model 3± 
   RR (CI 95%) RR (CI 95%) RR (CI 95%) 
GA at delivery 
Term > 37 weeks (ref) 12226 (90.4%) 627 (90.5%) -- -- -- 
Preterm < 37 weeks 1294 (9.6%) 66 (9.5%) 0.99 (0.79-1.26) 0.97 (0.72-1.32) 0.96 (0.71-1.31) 
Indicated PTB 403 (3.2%) 25 (3.8%) 1.21 (0.81-1.79) 1.23 (0.74-2.05) 1.23 (0.73-2.06) 
Spontaneous PTB 515 (4.0%) 24 (3.7%) 0.92 (0.61-1.37) 0.76 (0.44-1.31) 0.74 (0.43-1.28) 
Preeclampsia (PE) 
Normotensive (ref) 11376 (92.1%) 579 (91.5%) -- -- -- 
Overall PE 976 (7.9%) 54 (8.5%) 1.08 (0.83-1.40) 1.13 (0.84-1.53) 1.08 (0.80-1.47) 
Term PE  507 (4.3%) 38 (6.2%) 1.44 (1.05-1.99) 1.44 (1.01-2.06) 1.39 (0.97-2.00) 
Preterm PE 469 (4.0%) 16 (2.7%) 0.68 (0.42-1.11) 0.72 (0.40-1.30) 0.67 (0.37-1.22) 
Chorioamnionitis 
No (ref) 2588 (94.4%) 184 (93.4%) -- -- -- 
Yes 153 (5.6%) 13 (6.6%) 1.30 (1.00-1.70) 1.21 (0.90-1.63) 1.20 (0.88-1.63) 
Modified Poisson regression with robust error measurements were used to calculate unadjusted relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for maternal age, foreign born status, marital status, education, insurance type, alcohol and gestational 
age at first prenatal visit 







Table D. Chlamydia trachomatis infections among foreign born vs US born women and complications n=13,118, 2011-2017 
Variable CT positive n (%) Model 1¥ Model 2 β Model 3± 
GA at delivery 
Term > 37 weeks (ref) 481 (90.2%) -- -- -- 
Preterm <37 weeks 52 (9.8%) 1.06 (0.81-1.38) 0.96 (0.68-1.35) 0.91 (0.64-1.29) 
Indicated PTB 18 (3.6%) 1.25 (0.79-2.00) 1.10 (0.57-2.04) 1.02 (0.54-1.90) 
Spontaneous PTB 20 (4.0%) 1.04 (0.67-1.62) 0.82 (0.45-1.48) 0.76 (0.42-1.39) 
Preeclampsia (PE) 
Normotensive (ref) 449 (91.6%) -- -- -- 
Overall PE 41 (8.7%) 1.09 (0.81-1.48) 1.12 (0.80-1.57) 1.04 (0.74-1.46) 
Term PE  28 (5.9%) 1.40 (0.97-2.03) 1.36 (0.90-2.05) 1.30 (0.86-1.98) 
Preterm PE 13 (2.8%) 0.75 (0.44-1.29) 0.77 (0.40-1.48) 0.68 (0.35-1.31) 
Chorioamnionitis 
No (ref) 491 (92.8%) -- -- -- 
Yes 38 (7.2%) 1.21 (0.88-1.65) 1.20 (0.86-1.67) 1.22 (0.87-1.71) 
 
Modified Poisson regression with robust error measurements were used to calculate unadjusted relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for maternal age, race, marital status, education, insurance type, alcohol and gestational age at first 
prenatal visit 






Table E. Association between Chlamydia trachomatis and pregnancy outcomes among singleton nulliparous pregnancies N=5944, 
2011-2017   
Variable CT negative n 
(%) 
CT positive n 
(%) 
Model 1¥ Model 2 β Model 3± 
   RR (CI 95%) RR (CI 95%) RR (CI 95%) 
GA at delivery 
Term > 37 weeks (ref) 5146 (91.5%) 295 (91.6%) -- -- -- 
Preterm < 37 weeks 476 (8.5%) 27 (8.4%) 0.99 (0.68-1.43) 1.06 (0.67-1.67) 1.06 (0.67-1.66) 
Indicated PTB 128 (2.4%) 12 (3.9%) 1.62 (0.91-2.89) 2.46 (1.26-4.83) 2.46 (1.25-4.85) 
Spontaneous PTB 152 (2.8%) 9 (2.9%) 1.04 (0.53-2.01) 0.46 (0.15-1.45) 0.44 (0.14-1.38) 
Preeclampsia (PE) 
Normotensive (ref) 4528 (90.5%) 240 (85.4%) -- -- -- 
Overall PE 478 (9.6%) 41 (14.6%) 1.53 (1.14-2.05) 1.48 (1.06-2.07) 1.43 (1.02-2.00) 
Term PE  198 (4.2%) 15 (5.9%) 1.68 (1.14-2.46) 1.43 (0.92-2.23) 1.41 (0.89-2.22) 
Preterm PE 280 (5.8%) 26 (9.8%) 1.40 (0.84-2.34) 1.71 (0.98-2.99) 1.59 (0.91-2.78) 
Chorioamnionitis 
No (ref) 4950 (88.7) 274 (85.9%) -- -- -- 
Yes 634 (11.3%) 45 (14.1%) 1.24 (0.94-1.64) 1.24 (0.91-1.70) 1.22 (0.88-1.68) 
Modified Poisson regression with robust error measurements were used to calculate unadjusted relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for maternal age, race, foreign born status, marital status, education, insurance type, alcohol and 
gestational age at first prenatal visit 







Table F. Pregnancy outcomes and complications with Chlamydia trachomatis infections among women who initiated care in the 
first trimester 2011-2017, n=11040 
Variable CT negative n (%) CT positive n (%) Model 1¥ Model 2 β Model 3± 
GA at delivery 
Term > 37 weeks (ref) 8460 (79.1%) 273 (80.3%) -- -- -- 
Preterm <37 weeks 2240 (20.9%) 67 19.7%) 0.91 (0.63-1.31) 0.89 (0.58-1.35) 0.87 (0.57-1.34) 
Preterm Birth Subtypes 
Term Births (ref) 9793 (96.5%) 313 (95.1%) -- -- -- 
Indicated PTB 350 (4.5%) 16 (4.9%) 1.41 (0.86-2.30) 1.51 (0.87-2.63) 1.49 (0.85-2.61) 
Spontaneous PTB 311 (3.1%) 7 (2.2%) 0.71 (0.34-1.49) 0.59 (0.24-1.42) 0.57 (0.23-1.38) 
Preeclampsia and subtypes 
Preeclampsia (PE) 9092 (93.0%) 272 (89.8%) -- -- -- 
Overall PE 680 (7.0%) 31 (10.2%) 1.47 (1.04-2.07) 1.27 (0.89-1.80) 1.23 (0.86-1.75) 
Term PE  322 (3.4%) 19 (6.5%) 1.91 (1.22-2.99) 1.61 (1.02-2.52) 1.59 (1.01-2.51) 
Preterm PE 358 (3.8%) 12 (4.2%) 1.15 (0.63-1.96) 0.94 (0.51-1.74) 0.88 (0.47-1.62) 
Chorioamnionitis 
No (ref) 10025 (94.4%) 309 (91.7%) -- -- -- 
Yes 589 (5.6%) 28 (8.3%)) 1.50 (1.04-2.15) 1.28 (0.88-1.87) 1.33 (0.91-1.94) 
Modified Poisson regression with robust error measurements were used to calculate unadjusted relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for maternal age, race, marital status, education, insurance type, and alcohol  






Table G. Pregnancy outcomes and complications with Chlamydia trachomatis infections among women who initiated care in the second 
trimester 2011-2017, n=7285 
Variable CT negative n (%) CT positive n (%) Model 1¥ Model 2 β Model 3± 
GA at delivery 
Term > 37 weeks (ref) 5438 (79.2%) 326 (7.2%) -- -- -- 
Preterm <37 weeks 1425 (20.8%) 96 (22.8%) 1.26 (0.96-1.66) 1.28 (0.94-1.73) 1.27 (0.93-1.73) 
Preterm Birth Subtypes 
Term Births (ref) 6262 (96.9%) 374(95.4%) -- -- -- 
Indicated PTB 202 (3.1%) 18 (4.6%) 1.47 (0.92-2.35) 1.79 (1.06-3.01) 1.74 (1.03-2.95) 
Spontaneous PTB 228 (3.5%) 18 (4.6%) 1.31 (0.82-2.09) 1.12 (0.65-1.92) 1.07 (0.62-1.84) 
Preeclampsia and subtypes 
None (ref) 5841 (93.2%) 357 (91.8%) -- -- -- 
Overall PE 429 (6.8%) 32 (8.2%) 1.20 (0.85-1.70) 1.20 (0.83-1.73) 1.13 (0.78-1.63) 
Term PE  219 (6.1%) 22 (5.8%) 1.61 (1.05-2.46) 1.46 (0.92-2.29) 1.40 (0.89-2.21) 
Preterm PE 210 (3.5%) 10 (2.7%)    
Chorioamnionitis 
No (ref) 6425 (94.5%) 387 (92.8%) -- -- -- 
Yes 375 (5.5%) 30 (7.2%) 1.30 (0.91-1.87) 1.02 (0.69-1.50) 1.05 (0.71-1.57) 
Modified Poisson regression with robust error measurements were used to calculate unadjusted relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for maternal age, race, marital status, education, insurance type, and alcohol  






Table H. Pregnancy outcomes and complications with Chlamydia trachomatis infections among women who initiated care in 
the third trimester 2011-2017, n=1543 
Variable CT negative n 
(%) 
CT positive n 
(%) 
Model 1¥ Model 2 β Model 3± 
GA at delivery 
Term >37 weeks (ref) 1176 (81.2%) 71 (74.7%) -- -- -- 
Preterm <37 weeks 272 (18.8%) 24 (25.3%) 1.24 (0.62-2.48) 1.52 (0.67-3.45) 1.53 (0.68-3.44) 
Preterm Birth Subtypes 
Term Births (ref) 1351 (98.5%) 88 (96.7%) -- -- -- 
Indicated PTB 20 (1.5%) 3 (3.3%) 2.26 (0.68-7.46) 1.84 (0.40-8.42) 1.81 (0.39-8.27) 
Spontaneous PTB 48 (3.4%) 3 (3.3%) 0.96 (0.30-3.02) 1.04 (0.25-4.34) 1.05 (0.25-4.41) 
Preeclampsia and subtypes 
None (ref) 1245 (94.5%) 75 (91.5%) -- -- -- 
Overall PE 73 (5.5%) 7 (8.5%) 1.54 (0.73-3.24) 1.33 (0.53-3.32) 1.29 (0.52-3.22) 
Term PE  46 (3.6%) 3 (3.8%) 1.08 (0.34-3.39) 0.78 (0.18-3.29) 0.78 (0.18-3.30) 
Preterm PE 27 (2.1%) 4 (5.1%) 2.38 (0.86-6.65) 2.60 (0.76-8.86) 2.39 (0.70-8.22) 
Chorioamnionitis 
No (ref) 1347 (93.8%) 88 (92.6%) -- -- -- 
Yes 89 (6.2%) 7 (7.4%) 1.19 (0.57-2.49) 1.20 (0.58-2.47) 1.05 (0.48-2.30) 
Modified Poisson regression with robust error measurements were used to calculate unadjusted relative risk 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for maternal age, race, marital status, education, insurance type, and alcohol 






Table I. Pregnancy outcomes and complications with Chlamydia trachomatis infections among women who 
initiated care in the third trimester 2011-2017, n=1543 
Variable CT negative n 
(%) 
CT positive n 
(%) 
Model 1¥ Model 2 β Model 3± 
GA at delivery 
Term >37 weeks (ref) 1176 (81.2%) 71 (74.7%) -- -- -- 
Preterm <37 weeks 272 (18.8%) 24 (25.3%) 1.34 (0.94-1.93) 1.44 (1.00-2.08) 1.31 (0.82-2.16) 
Preterm Birth Subtypes 
Term Births (ref) 1351 (98.5%) 88 (96.7%) -- -- -- 
Indicated PTB 20 (1.5%) 3 (3.3%) 2.26 (0.68-7.46) 1.99 (0.56-7.06) * 
Spontaneous PTB 48 (3.4%) 3 (3.3%) 0.96 (0.30-3.02) * * 
Preeclampsia and subtypes 
None (ref) 1245 (94.5%) 75 (91.5%) -- -- -- 
Overall PE 73 (5.5%) 7 (8.5%) 1.54 (0.73-3.24) 1.65 (0.77-3.54) * 
Term PE  46 (3.6%) 3 (3.8%) 1.08 (0.34-3.39) 1.08 (0.34-3.43) * 
Preterm PE 27 (2.1%) 4 (5.1%) 2.38 (0.86-6.65) 2.77 (0.97-7.87) * 
*Relative risk was not calculated due to small sample size 
¥Unadjusted estimates  
β Estimates were adjusted for maternal age, race, marital status, alcohol and tobacco use 
±Model 2 adjustments plus maternal comorbidities, HIV, Gonorrhea, and Bacterial vaginosis 
 
 
 
